{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:28:40Z","timestamp":1793406520093,"version":"4.5.0"},"reference-count":276,"publisher":"Bentham Science Publishers Ltd.","issue":"12","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2020,12,2]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Obesity represents one of the most important health problems worldwide with increasing\nmorbidity and mortality. Widespread prevalence of this disease justifies its actual definition of\na \u201cglobal epidemic\u201d. Adipose tissue is nowadays considered a complex organ with lots of endocrine\nand metabolic functions. In addition to fulfilling its task for energy storage and thermal regulation,\nby virtue of its constituent white and brown cells, adipose tissue represents, considering its\nsize, the biggest endocrine gland in the body. Both adipocytes and surrounding resident cells\n(macrophages, endothelial cells and others) produce a huge number of molecules, or adipokines,\nwith endocrine or paracrine functions, that regulate various aspects of metabolism whose clinical\nrelevance is emerging. By balancing pro-inflammatory and anti-inflammatory effects, the\nadipokines control insulin sensitivity and related glucose metabolism changes, lipid accumulation\nin the liver and other organs, and finally gonadal function. Collectively, literature data remains\ncloudy because of still conflicting results of pre-clinical and clinical studies. The aim of this review\nwas to summarize scientific evidence about adipokines\u2019 effects on human metabolism, by focusing\non their role on either Metabolic Syndrome and NAFLD, or insulin-resistance in pregnancy, or\nfinally, reproductive function disorders.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866527666200505214555","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T08:50:27Z","timestamp":1588755027000},"page":"1204-1230","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Adipokines: A Rainbow of Proteins with Metabolic and Endocrine Functions"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4945-935X","authenticated-orcid":true,"given":"Sara","family":"Parrettini","sequence":"first","affiliation":[{"name":"Division of Medical Andrology and Endocrinology of Reproduction, University of Perugia and \u201cS. Maria\u201d Hospital, Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9804-5084","authenticated-orcid":true,"given":"Massimiliano","family":"Cavallo","sequence":"additional","affiliation":[{"name":"Division of Medical Andrology and Endocrinology of Reproduction, University of Perugia and \u201cS. Maria\u201d Hospital, Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-8060","authenticated-orcid":true,"given":"Francesco","family":"Gaggia","sequence":"additional","affiliation":[{"name":"Division of Medical Andrology and Endocrinology of Reproduction, University of Perugia and \u201cS. Maria\u201d Hospital, Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7560-0081","authenticated-orcid":true,"given":"Riccardo","family":"Calafiore","sequence":"additional","affiliation":[{"name":"Division of Medical Andrology and Endocrinology of Reproduction, University of Perugia and \u201cS. Maria\u201d Hospital, Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4445-164X","authenticated-orcid":true,"given":"Giovanni","family":"Luca","sequence":"additional","affiliation":[{"name":"Division of Medical Andrology and Endocrinology of Reproduction, University of Perugia and \u201cS. Maria\u201d Hospital, Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11883-014-0409-1","volume":"16","author":"Bays H.","year":"2014","unstructured":"Bays H.; Adiposopathy, \u201csick fat,\u201d Ockham\u2019s razor, and resolution of the obesity paradox. Curr Atheroscler Rep 2014,16(5),409","journal-title":"Curr Atheroscler Rep"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s40618-019-01052-3","volume":"42","author":"Barchetta I.","year":"2019","unstructured":"Barchetta I.; Cimini F.A.; Ciccarelli G.; Baroni M.G.; Cavallo M.G.; Sick fat: The good and the bad of old and new circulating markers of adipose tissue inflammation. J Endocrinol Invest 2019,42(11),1257-1272","journal-title":"J Endocrinol Invest"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3390\/ijms18010008","volume":"18","author":"Oh K.J.","year":"2016","unstructured":"Oh K.J.; Lee D.S.; Kim W.K.; Han B.S.; Lee S.C.; Bae K.H.; Metabolic adaptation in obesity and type II diabetes: Myokines, adipokines and hepatokines. Int J Mol Sci 2016,18(1),E8","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"E3893","DOI":"10.3390\/ijms20163893","volume":"20","author":"Song P.","year":"2019","unstructured":"Song P.; Kwon Y.; Joo J.Y.; Kim D.G.; Yoon J.H.; Secretomics to discover regulators in diseases. Int J Mol Sci 2019,20(16),E3893","journal-title":"Int J Mol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fendo.2014.00107","volume":"5","author":"Itoh N.","year":"2014","unstructured":"Itoh N.; FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases. Front Endocrinol (Lausanne) 2014,5,107","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2012.258","volume":"9","author":"Stefan N.","year":"2013","unstructured":"Stefan N.; H\u00e4ring H.U.; The role of hepatokines in metabolism. Nat Rev Endocrinol 2013,9(3),144-152","journal-title":"Nat Rev Endocrinol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"E854","DOI":"10.3390\/jcm8060854","volume":"8","author":"Lee M.W.","year":"2019","unstructured":"Lee M.W.; Lee M.; Oh K.J.; Adipose tissue-derived signatures for obesity and type 2 diabetes: Adipokines, batokines and microRNAs. J Clin Med 2019,8(6),E854","journal-title":"J Clin Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1242\/dmm.009662","volume":"5","author":"Cinti S.","year":"2012","unstructured":"Cinti S.; The adipose organ at a glance. Dis Model Mech 2012,5(5),588-594","journal-title":"Dis Model Mech"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-59745-245-8_1","volume":"456","author":"Fr\u00fchbeck G.","year":"2008","unstructured":"Fr\u00fchbeck G.; Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol Biol 2008,456,1-22","journal-title":"Methods Mol Biol"},{"key":"ref=10","author":"Cinti S.","year":"1999","unstructured":"Cinti S.;  The Adipose Organ 1999","journal-title":"The Adipose Organ"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/cphy.c170042","volume":"8","author":"Cinti S.","year":"2018","unstructured":"Cinti S.; Adipose organ development and remodeling. Compr Physiol 2018,8(4),1357-1431","journal-title":"Compr Physiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"E827","DOI":"10.1152\/ajpendo.2001.280.6.E827","volume":"280","author":"Fr\u00fchbeck G.","year":"2001","unstructured":"Fr\u00fchbeck G.; G\u00f3mez-Ambrosi J.; Muruz\u00e1bal F.J.; Burrell M.A.; The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001,280(6),E827-E847","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","volume":"150","author":"Wu J.","year":"2012","unstructured":"Wu J.; Bostr\u00f6m P.; Sparks L.M.; Ye L.; Choi J.H.; Giang A.H.; Khandekar M.; Virtanen K.A.; Nuutila P.; Schaart G.; Huang K.; Tu H.; van Marken Lichtenbelt W.D.; Hoeks J.; Enerb\u00e4ck S.; Schrauwen P.; Spiegelman B.M.; Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012,150(2),366-376","journal-title":"Cell"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","volume":"17","author":"Tchkonia T.","year":"2013","unstructured":"Tchkonia T.; Thomou T.; Zhu Y.; Karagiannides I.; Pothoulakis C.; Jensen M.D.; Kirkland J.L.; Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab 2013,17(5),644-656","journal-title":"Cell Metab"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"R159","DOI":"10.1530\/EJE-13-0945","volume":"170","author":"Giordano A.","year":"2014","unstructured":"Giordano A.; Smorlesi A.; Frontini A.; Barbatelli G.; Cinti S.; White, brown and pink adipocytes: The extraordinary plasticity of the adipose organ. Eur J Endocrinol 2014,170(5),R159-R171","journal-title":"Eur J Endocrinol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","volume":"360","author":"Cypess A.M.","year":"2009","unstructured":"Cypess A.M.; Lehman S.; Williams G.; Tal I.; Rodman D.; Goldfine A.B.; Kuo F.C.; Palmer E.L.; Tseng Y.H.; Doria A.; Kolodny G.M.; Kahn C.R.; Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009,360(15),1509-1517","journal-title":"N Engl J Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","volume":"360","author":"Virtanen K.A.","year":"2009","unstructured":"Virtanen K.A.; Lidell M.E.; Orava J.; Heglind M.; Westergren R.; Niemi T.; Taittonen M.; Laine J.; Savisto N.J.; Enerb\u00e4ck S.; Nuutila P.; Functional brown adipose tissue in healthy adults. N Engl J Med 2009,360(15),1518-1525","journal-title":"N Engl J Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00015.2003","volume":"84","author":"Cannon B.","year":"2004","unstructured":"Cannon B.; Nedergaard J.; Brown adipose tissue: Function and physiological significance. Physiol Rev 2004,84(1),277-359","journal-title":"Physiol Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMcibr0809610","volume":"360","author":"Enerb\u00e4ck S.","year":"2009","unstructured":"Enerb\u00e4ck S.; The origins of brown adipose tissue. N Engl J Med 2009,360(19),2021-2023","journal-title":"N Engl J Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"E691","DOI":"10.1152\/ajpendo.00297.2015","volume":"309","author":"Rodr\u00edguez A.","year":"2015","unstructured":"Rodr\u00edguez A.; Ezquerro S.; M\u00e9ndez-Gim\u00e9nez L.; Becerril S.; Fr\u00fchbeck G.; Revisiting the adipocyte: A model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol Endocrinol Metab 2015,309(8),E691-E714","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nm.3017","volume":"19","author":"Lidell M.E.","year":"2013","unstructured":"Lidell M.E.; Betz M.J.; Dahlqvist Leinhard O.; Heglind M.; Elander L.; Slawik M.; Mussack T.; Nilsson D.; Romu T.; Nuutila P.; Virtanen K.A.; Beuschlein F.; Persson A.; Borga M.; Enerb\u00e4ck S.; Evidence for two types of brown adipose tissue in humans. Nat Med 2013,19(5),631-634","journal-title":"Nat Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1152\/physiolgenomics.00039.2012","volume":"44","author":"Becerril S.","year":"2012","unstructured":"Becerril S.; Rodr\u00edguez A.; Catal\u00e1n V.; S\u00e1inz N.; Ram\u00edrez B.; G\u00f3mez-Ambrosi J.; Fr\u00fchbeck G.; Transcriptional analysis of brown adipose tissue in leptin-deficient mice lacking inducible nitric oxide synthase: Evidence of the role of Med1 in energy balance. Physiol Genomics 2012,44(13),678-688","journal-title":"Physiol Genomics"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"E977","DOI":"10.1152\/ajpendo.00183.2009","volume":"297","author":"Cinti S.","year":"2009","unstructured":"Cinti S.; Transdifferentiation properties of adipocytes in the adipose organ. Am J Physiol Endocrinol Metab 2009,297(5),E977-E986","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/prca.201100052","volume":"6","author":"Lehr S.","year":"2012","unstructured":"Lehr S.; Hartwig S.; Sell H.; Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clin Appl 2012,6(1-2),91-101","journal-title":"Proteomics Clin Appl"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nature06902","volume":"453","author":"Spalding K.L.","year":"2008","unstructured":"Spalding K.L.; Arner E.; Westermark P.O.; Bernard S.; Buchholz B.A.; Bergmann O.; Blomqvist L.; Hoffstedt J.; N\u00e4slund E.; Britton T.; Concha H.; Hassan M.; Ryd\u00e9n M.; Fris\u00e9n J.; Arner P.; Dynamics of fat cell turnover in humans. Nature 2008,453(7196),783-787","journal-title":"Nature"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00125-018-4732-x","volume":"62","author":"White U.","year":"2019","unstructured":"White U.; Ravussin E.; Dynamics of adipose tissue turnover in human metabolic health and disease. Diabetologia 2019,62(1),17-23","journal-title":"Diabetologia"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.metabol.2006.11.015","volume":"56","author":"Boivin A.","year":"2007","unstructured":"Boivin A.; Brochu G.; Marceau S.; Marceau P.; Hould F.S.; Tchernof A.; Regional differences in adipose tissue metabolism in obese men. Metabolism 2007,56(4),533-540","journal-title":"Metabolism"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00125-007-0841-7","volume":"51","author":"Perrini S.","year":"2008","unstructured":"Perrini S.; Laviola L.; Cignarelli A.; Melchiorre M.; De Stefano F.; Caccioppoli C.; Natalicchio A.; Orlando M.R.; Garruti G.; De Fazio M.; Catalano G.; Memeo V.; Giorgino R.; Giorgino F.; Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia 2008,51(1),155-164","journal-title":"Diabetologia"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"jeb162958","DOI":"10.1242\/jeb.162958","volume":"221","author":"Schoettl T.","year":"2018","unstructured":"Schoettl T.; Fischer IP.; Ussar S.; Heterogeneity of adipose tissue in development and metabolic function. J Exp Biol 2018,221(Pt Suppl 1),jeb162958","journal-title":"J Exp Biol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"Weisberg S.P.","year":"2003","unstructured":"Weisberg S.P.; McCann D.; Desai M.; Rosenbaum M.; Leibel R.L.; Ferrante A.W.Jr.; Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003,112(12),1796-1808","journal-title":"J Clin Invest"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"Lumeng C.N.","year":"2007","unstructured":"Lumeng C.N.; Bodzin J.L.; Saltiel A.R.; Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007,117(1),175-184","journal-title":"J Clin Invest"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/ATVBAHA.108.165100","volume":"28","author":"Kintscher U.","year":"2008","unstructured":"Kintscher U.; Hartge M.; Hess K.; Foryst-Ludwig A.; Clemenz M.; Wabitsch M.; Fischer-Posovszky P.; Barth T.F.; Dragun D.; Skurk T.; Hauner H.; Bl\u00fcher M.; Unger T.; Wolf A.M.; Knippschild U.; Hombach V.; Marx N.; T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008,28(7),1304-1310","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1038\/s41598-018-22962-x","volume":"8","author":"Verboven K.","year":"2018","unstructured":"Verboven K.; Wouters K.; Gaens K.; Hansen D.; Bijnen M.; Wetzels S.; Stehouwer C.D.; Goossens G.H.; Schalkwijk C.G.; Blaak E.E.; Jocken J.W.; Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Sci Rep 2018,8(1),4677","journal-title":"Sci Rep"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cca.2019.06.019","volume":"496","author":"Reddy P.","year":"2019","unstructured":"Reddy P.; Lent-Schochet D.; Ramakrishnan N.; McLaughlin M.; Jialal I.; Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes. Clin Chim Acta 2019,496,35-44","journal-title":"Clin Chim Acta"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"E1649","DOI":"10.3390\/ijms18081649","volume":"18","author":"Adolph T.E.","year":"2017","unstructured":"Adolph T.E.; Grander C.; Grabherr F.; Tilg H.; Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. Int J Mol Sci 2017,18(8),E1649","journal-title":"Int J Mol Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1530\/JOE-18-0032","volume":"238","author":"\u0160imj\u00e1k P.","year":"2018","unstructured":"\u0160imj\u00e1k P.; Cinkajzlov\u00e1 A.; Anderlov\u00e1 K.; Pa\u0159\u00edzek A.; Mr\u00e1z M.; Kr\u0161ek M.; Haluz\u00edk M.; The role of obesity and adipose tissue dysfunction in gestational diabetes mellitus. J Endocrinol 2018,238(2),R63-R77","journal-title":"J Endocrinol"},{"key":"ref=37","unstructured":"Standards of Medical Care in Diabetes 2019. ADA (American Diabetes Association)Diabetes Care,  2019, 42(Suppl. 1), 1-186."},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1177\/1933719109336614","volume":"16","author":"Briana D.D.","year":"2009","unstructured":"Briana D.D.; Malamitsi-Puchner A.; Reviews: Adipocytokines in normal and complicated pregnancies. Reprod Sci 2009,16(10),921-937","journal-title":"Reprod Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.fertnstert.2012.12.022","volume":"99","author":"Thomas S.","year":"2013","unstructured":"Thomas S.; Kratzsch D.; Schaab M.; Scholz M.; Grunewald S.; Thiery J.; Paasch U.; Kratzsch J.; Seminal plasma adipokine levels are\u00a0correlated with functional characteristics of spermatozoa. Fertil Steril 2013,99(5),1256-1263.e3","journal-title":"Fertil Steril"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0014-5793(02)03697-9","volume":"532","author":"Viengchareun S.","year":"2002","unstructured":"Viengchareun S.; Zennaro M.C.; Pascual-Le Tallec L.; Lombes M.; Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin. FEBS Lett 2002,532(3),345-350","journal-title":"FEBS Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270","author":"Scherer P.E.","year":"1995","unstructured":"Scherer P.E.; Williams S.; Fogliano M.; Baldini G.; Lodish H.F.; A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995,270(45),26746-26749","journal-title":"J Biol Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1463-1326.2006.00610.x","volume":"9","author":"Oh D.K.","year":"2007","unstructured":"Oh D.K.; Ciaraldi T.; Henry R.R.; Adiponectin in health and disease. Diabetes Obes Metab 2007,9(3),282-289","journal-title":"Diabetes Obes Metab"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.beem.2013.09.003","volume":"28","author":"Yamauchi T.","year":"2014","unstructured":"Yamauchi T.; Iwabu M.; Okada-Iwabu M.; Kadowaki T.; Adiponectin receptors: A review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab 2014,28(1),15-23","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"E1321","DOI":"10.3390\/ijms18061321","volume":"18","author":"Achari A.E.","year":"2017","unstructured":"Achari A.E.; Jain S.K.; Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci 2017,18(6),E1321","journal-title":"Int J Mol Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm788","volume":"8","author":"Yamauchi T.","year":"2002","unstructured":"Yamauchi T.; Kamon J.; Minokoshi Y.; Ito Y.; Waki H.; Uchida S.; Yamashita S.; Noda M.; Kita S.; Ueki K.; Eto K.; Akanuma Y.; Froguel P.; Foufelle F.; Ferre P.; Carling D.; Kimura S.; Nagai R.; Kahn B.B.; Kadowaki T.; Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002,8(11),1288-1295","journal-title":"Nat Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1385\/ENDO:30:2:217","volume":"30","author":"Gu W.","year":"2006","unstructured":"Gu W.; Li X.; Liu C.; Yang J.; Ye L.; Tang J.; Gu Y.; Yang Y.; Hong J.; Zhang Y.; Chen M.; Ning G.; Globular adiponectin augments insulin secretion from pancreatic islet beta cells at high glucose concentrations. Endocrine 2006,30(2),217-221","journal-title":"Endocrine"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1172\/JCI31021","volume":"117","author":"Kim J-Y.","year":"2007","unstructured":"Kim J-Y.; van de Wall E.; Laplante M.; Azzara A.; Trujillo M.E.; Hofmann S.M.; Schraw T.; Durand J.L.; Li H.; Li G.; Jelicks L.A.; Mehler M.F.; Hui D.Y.; Deshaies Y.; Shulman G.I.; Schwartz G.J.; Scherer P.E.; Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007,117(9),2621-2637","journal-title":"J Clin Invest"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"5187940","DOI":"10.1155\/2018\/5187940","volume":"2018","author":"Abdella N.A.","year":"2018","unstructured":"Abdella N.A.; Mojiminiyi O.A.; Clinical applications of adiponectin measurements in type 2 diabetes mellitus: Screening, diagnosis, and marker of diabetes control. Dis Markers 2018,2018,5187940","journal-title":"Dis Markers"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1210\/jc.2016-1207","volume":"101","author":"Ma W.","year":"2016","unstructured":"Ma W.; Huang T.; Zheng Y.; Wang M.; Bray G.A.; Sacks F.M.; Qi L.; Weight-loss diets, adiponectin, and changes in cardiometabolic risk in the 2-Year POUNDS lost trial. J Clin Endocrinol Metab 2016,101(6),2415-2422","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"E2069","DOI":"10.3390\/nu11092069","volume":"11","author":"Unamuno X.","year":"2019","unstructured":"Unamuno X.; Izaguirre M.; G\u00f3mez-Ambrosi J.; Rodr\u00edguez A.; Ram\u00edrez B.; Becerril S.; Valent\u00ed V.; Moncada R.; Silva C.; Salvador J.; Portincasa P.; Fr\u00fchbeck G.; Catal\u00e1n V.; Increase of the adiponectin\/leptin in with obesity and type 2 diabetes after Roux-en-Y gastric bypass. Nutrients 2019,11(9),E2069","journal-title":"Nutrients"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"E2195","DOI":"10.3390\/nu11092195","volume":"11","author":"Corbi G.","year":"2019","unstructured":"Corbi G.; Polito R.; Monaco M.L.; Cacciatore F.; Scioli M.; Ferrara N.; Daniele A.; Nigro E.; Adiponectin expression and genotypes in italian people with severe obesity undergone a hypocaloric diet and physical exercise program. Nutrients 2019,11(9),E2195","journal-title":"Nutrients"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"E97","DOI":"10.3390\/medsci6040097","volume":"6","author":"Becic T.","year":"2018","unstructured":"Becic T.; Studenik C.; Hoffmann G.; Exercise increases adiponectin and reduces leptin levels in prediabetic and diabetic individuals: Systematic review and meta-analysis of randomized controlled trials. Med Sci (Basel) 2018,6(4),E97","journal-title":"Med Sci (Basel)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ijo.2015.134","volume":"40","author":"Quaresma P.G.","year":"2016","unstructured":"Quaresma P.G.; Reencober N.; Zanotto T.M.; Santos A.C.; Weissmann L.; de Matos A.H.; Lopes-Cendes I.; Folli F.; Saad M.J.; Prada P.O.; Pioglitazone treatment increases food intake and decreases energy expenditure partially via hypothalamic adiponectin\/adipoR1\/AMPK pathway. Int J Obes 2016,40(1),138-146","journal-title":"Int J Obes"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","volume":"45","author":"Summers S.A.","year":"2006","unstructured":"Summers S.A.; Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006,45(1),42-72","journal-title":"Prog Lipid Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm.2277","volume":"17","author":"Holland W.L.","year":"2011","unstructured":"Holland W.L.; Miller R.A.; Wang Z.V.; Sun K.; Barth B.M.; Bui H.H.; Davis K.E.; Bikman B.T.; Halberg N.; Rutkowski J.M.; Wade M.R.; Tenorio V.M.; Kuo M.S.; Brozinick J.T.; Zhang B.B.; Birnbaum M.J.; Summers S.A.; Scherer P.E.; Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011,17(1),55-63","journal-title":"Nat Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00125-018-4777-x","volume":"62","author":"Scherer P.E.","year":"2019","unstructured":"Scherer P.E.; The many secret lives of adipocytes: Implications for diabetes. Diabetologia 2019,62(2),223-232","journal-title":"Diabetologia"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cmet.2007.06.003","volume":"6","author":"Kubota N.","year":"2007","unstructured":"Kubota N.; Yano W.; Kubota T.; Yamauchi T.; Itoh S.; Kumagai H.; Kozono H.; Takamoto I.; Okamoto S.; Shiuchi T.; Suzuki R.; Satoh H.; Tsuchida A.; Moroi M.; Sugi K.; Noda T.; Ebinuma H.; Ueta Y.; Kondo T.; Araki E.; Ezaki O.; Nagai R.; Tobe K.; Terauchi Y.; Ueki K.; Minokoshi Y.; Kadowaki T.; Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007,6(1),55-68","journal-title":"Cell Metab"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jhep.2009.06.016","volume":"51","author":"Moschen A.R.","year":"2009","unstructured":"Moschen A.R.; Molnar C.; Wolf A.M.; Weiss H.; Graziadei I.; Kaser S.; Ebenbichler C.F.; Stadlmann S.; Moser P.L.; Tilg H.; Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol 2009,51(4),765-777","journal-title":"J Hepatol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.metabol.2005.01.020","volume":"54","author":"Maeda K.","year":"2005","unstructured":"Maeda K.; Ishihara K.; Miyake K.; Kaji Y.; Kawamitsu H.; Fujii M.; Sugimura K.; Ohara T.; Inverse correlation between serum adiponectin concentration and hepatic lipid content in Japanese with type 2 diabetes. Metabolism 2005,54(6),775-780","journal-title":"Metabolism"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.metabol.2010.09.003","volume":"60","author":"Polyzos S.A.","year":"2011","unstructured":"Polyzos S.A.; Toulis K.A.; Goulis D.G.; Zavos C.; Kountouras J.; Serum total adiponectin in nonalcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism 2011,60(3),313-326","journal-title":"Metabolism"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/hep.26072","volume":"57","author":"van der Poorten D.","year":"2013","unstructured":"van der Poorten D.; Samer C.F.; Ramezani-Moghadam M.; Coulter S.; Kacevska M.; Schrijnders D.; Wu L.E.; McLeod D.; Bugianesi E.; Komuta M.; Roskams T.; Liddle C.; Hebbard L.; George J.; Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause? Hepatology 2013,57(6),2180-2188","journal-title":"Hepatology"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13813455.2019.1661496","author":"Ebrahimi R.","year":"2019","unstructured":"Ebrahimi R.; Shanaki M.; Mohassel Azadi S.; Bahiraee A.; Radmard A.R.; Poustchi H.; Emamgholipour S.; Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: Is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices? Arch Physiol Biochem 2019,1-8","journal-title":"Arch Physiol Biochem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ajg.2016.318","volume":"112","author":"Feldman A.","year":"2017","unstructured":"Feldman A.; Eder S.K.; Felder T.K.; Kedenko L.; Paulweber B.; Stadlmayr A.; Huber-Sch\u00f6nauer U.; Niederseer D.; Stickel F.; Auer S.; Haschke-Becher E.; Patsch W.; Datz C.; Aigner E.; Clinical and metabolic characterization of lean caucasian subjects with non-alcoholic fatty liver. Am J Gastroenterol 2017,112(1),102-110","journal-title":"Am J Gastroenterol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/hep.24097","volume":"53","author":"Ayonrinde O.T.","year":"2011","unstructured":"Ayonrinde O.T.; Olynyk J.K.; Beilin L.J.; Mori T.A.; Pennell C.E.; de Klerk N.; Oddy W.H.; Shipman P.; Adams L.A.; Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011,53(3),800-809","journal-title":"Hepatology"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00125-015-3855-6","volume":"59","author":"Iliodromiti S.","year":"2016","unstructured":"Iliodromiti S.; Sassarini J.; Kelsey T.W.; Lindsay R.S.; Sattar N.; Nelson S.M.; Accuracy of circulating adiponectin for predicting gestational diabetes: A systematic review and meta-analysis. Diabetologia 2016,59(4),692-699","journal-title":"Diabetologia"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/GRF.0b013e31815a5494","volume":"50","author":"Lain K.Y.","year":"2007","unstructured":"Lain K.Y.; Catalano P.M.; Metabolic changes in pregnancy. Clin Obstet Gynecol 2007,50(4),938-948","journal-title":"Clin Obstet Gynecol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13098-017-0234-0","volume":"9","author":"Saucedo R.","year":"2017","unstructured":"Saucedo R.; Valencia J.; Gutierrez C.; Basurto L.; Hernandez M.; Puello E.; Rico G.; Vega G.; Zarate A.; Gene variants in the FTO gene are associated with adiponectin and TNF-alpha levels in gestational diabetes mellitus. Diabetol Metab Syndr 2017,9,32","journal-title":"Diabetol Metab Syndr"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1210\/jc.2017-00289","volume":"102","author":"Lekva T.","year":"2017","unstructured":"Lekva T.; Roland M.C.P.; Michelsen A.E.; Friis C.M.; Aukrust P.; Bollerslev J.; Henriksen T.; Ueland T.; Large reduction in adiponectin during pregnancy is associated with large-for-gestational-age newborns. J Clin Endocrinol Metab 2017,102(7),2552-2559","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1210\/en.2007-1582","volume":"149","author":"Caminos J.E.","year":"2008","unstructured":"Caminos J.E.; Nogueiras R.; Gayt\u00e1n F.; Pineda R.; Gonz\u00e1lez C.R.; Barreiro M.L.; Casta\u00f1o J.P.; Malag\u00f3n M.M.; Pinilla L.; Toppari J.; Di\u00e9guez C.; Tena-Sempere M.; Novel expression and direct effects of adiponectin in the rat testis. Endocrinology 2008,149(7),3390-3402","journal-title":"Endocrinology"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1111\/febs.12391","volume":"280","author":"Wu L.","year":"2013","unstructured":"Wu L.; Xu B.; Fan W.; Zhu X.; Wang G.; Zhang A.; Adiponectin protects Leydig cells against proinflammatory cytokines by suppressing the nuclear factor-\u03baB signaling pathway. FEBS J 2013,280(16),3920-3927","journal-title":"FEBS J"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1515\/hmbci-2015-0046","volume":"24","author":"Roumaud P.","year":"2015","unstructured":"Roumaud P.; Martin L.J.; Roles of leptin, adiponectin and resistin in the transcriptional regulation of steroidogenic genes contributing to decreased Leydig cells function in obesity. Horm Mol Biol Clin Investig 2015,24(1),25-45","journal-title":"Horm Mol Biol Clin Investig"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"R215","DOI":"10.1530\/REP-17-0002","volume":"153","author":"Rak A.","year":"2017","unstructured":"Rak A.; Mellouk N.; Froment P.; Dupont J.; Adiponectin and resistin: potential metabolic signals affecting hypothalamo-pituitary gonadal axis in females and males of different species. Reproduction 2017,153(6),R215-R226","journal-title":"Reproduction"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"3906490","DOI":"10.1155\/2018\/3906490","volume":"2018","author":"Elfassy Y.","year":"2018","unstructured":"Elfassy Y.; Bastard J-P.; McAvoy C.; Fellahi S.; Dupont J.; Levy R.; Adipokines in semen: physiopathology and effects on spermatozoas. Int J Endocrinol 2018,2018,3906490","journal-title":"Int J Endocrinol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.fertnstert.2008.09.008","volume":"92","author":"Chabrolle C.","year":"2009","unstructured":"Chabrolle C.; Tosca L.; Ram\u00e9 C.; Lecomte P.; Roy\u00e8re D.; Dupont J.; Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil Steril 2009,92(6),1988-1996","journal-title":"Fertil Steril"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.fertnstert.2008.02.006","volume":"91","author":"Gutman G.","year":"2009","unstructured":"Gutman G.; Barak V.; Maslovitz S.; Amit A.; Lessing J.B.; Geva E.; Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: Implications for enhanced insulin sensitivity. Fertil Steril 2009,91(5),1837-1841","journal-title":"Fertil Steril"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.fertnstert.2012.04.050","volume":"98","author":"Richards J.S.","year":"2012","unstructured":"Richards J.S.; Liu Z.; Kawai T.; Tabata K.; Watanabe H.; Suresh D.; Kuo F.T.; Pisarska M.D.; Shimada M.; Adiponectin and its receptors modulate granulosa cell and cumulus cell functions, fertility, and early embryo development in the mouse and human. Fertil Steril 2012,98(2),471-9.e1","journal-title":"Fertil Steril"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10815-013-0012-3","volume":"30","author":"Wickham E.P.","year":"2013","unstructured":"Wickham E.P.; Tao T.; Nestler J.E.; McGee E.A.; Activation of the LH receptor up regulates the type 2 adiponectin receptor in human granulosa cells. J Assist Reprod Genet 2013,30(7),963-968","journal-title":"J Assist Reprod Genet"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/cphy.c160043","volume":"7","author":"Watanabe T.","year":"2017","unstructured":"Watanabe T.; Watanabe-Kominato K.; Takahashi Y.; Kojima M.; Watanabe R.; Adipose tissue-derived omentin-1 function and regulation. Compr Physiol 2017,7(3),765-781","journal-title":"Compr Physiol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","volume":"290","author":"Yang R.Z.","year":"2006","unstructured":"Yang R.Z.; Lee M.J.; Hu H.; Pray J.; Wu H.B.; Hansen B.C.; Shuldiner A.R.; Fried S.K.; McLenithan J.C.; Gong D.W.; Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006,290(6),E1253-E1261","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2337\/db06-1506","volume":"56","author":"de Souza Batista C.M.","year":"2007","unstructured":"de Souza Batista C.M.; Yang R.Z.; Lee M.J.; Glynn N.M.; Yu D.Z.; Pray J.; Ndubuizu K.; Patil S.; Schwartz A.; Kligman M.; Fried S.K.; Gong D.W.; Shuldiner A.R.; Pollin T.I.; McLenithan J.C.; Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007,56(6),1655-1661","journal-title":"Diabetes"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.diabres.2010.01.013","volume":"88","author":"Pan H.Y.","year":"2010","unstructured":"Pan H.Y.; Guo L.; Li Q.; Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010,88(1),29-33","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=82","first-page":"363","volume":"68","author":"Waluga M.","year":"2017","unstructured":"Waluga M.; Kukla M.; Zorniak M.; Kajor M.; Liszka L.; Dyaczynski M.; Kowalski G.; Zadlo D.; Waluga E.; Olczyk P.; Buldak R.J.; Berdowska A.; Hartleb M.; Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease. J Physiol Pharmacol 2017,68(3),363-374","journal-title":"J Physiol Pharmacol"},{"key":"ref=83","first-page":"11","volume":"5","author":"Kohan L.","year":"2016","unstructured":"Kohan L.; Safarpur M.; Abdollahi H.; Omentin-1 rs2274907 and resistin rs1862513 polymorphisms influence genetic susceptibility to nonalcoholic fatty liver disease. Mol Biol Res Commun 2016,5(1),11-17","journal-title":"Mol Biol Res Commun"},{"key":"ref=84","first-page":"1231","volume":"36","author":"Pan B.L.","year":"2016","unstructured":"Pan B.L.; Ma R.M.; Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus. Nan Fang Yi Ke Da Xue Xue Bao 2016,36(9),1231-1236","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/0004563214541247","volume":"52","author":"Liu H.","year":"2015","unstructured":"Liu H.; Wu J.; Wang H.; Sheng L.; Tang N.; Li Y.; Hao T.; Association of serum omentin-1 concentrations with the presence and severity of preeclampsia. Ann Clin Biochem 2015,52(Pt 2),245-250","journal-title":"Ann Clin Biochem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1095\/biolreprod.114.120410","volume":"91","author":"Cloix L.","year":"2014","unstructured":"Cloix L.; Reverchon M.; Cornuau M.; Froment P.; Ram\u00e9 C.; Costa C.; Froment G.; Lecomte P.; Chen W.; Roy\u00e8re D.; Guerif F.; Dupont J.; Expression and regulation of INTELECTIN1 in human granulosa-lutein cells: role in IGF-1-induced steroidogenesis through NAMPT. Biol Reprod 2014,91(2),50","journal-title":"Biol Reprod"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ando.2015.08.002","volume":"76","author":"Yang H.Y.","year":"2015","unstructured":"Yang H.Y.; Ma Y.; Lu X.H.; Liang X.H.; Suo Y.J.; Huang Z.X.; Lu D.C.; Qin Y.F.; Luo Z.J.; The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Ann Endocrinol (Paris) 2015,76(5),620-627","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1126\/science.1188280","volume":"329","author":"Ouchi N.","year":"2010","unstructured":"Ouchi N.; Higuchi A.; Ohashi K.; Oshima Y.; Gokce N.; Shibata R.; Akasaki Y.; Shimono A.; Walsh K.; Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 2010,329(5990),454-457","journal-title":"Science"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12933-017-0591-x","volume":"16","author":"Carstensen-Kirberg M.","year":"2017","unstructured":"Carstensen-Kirberg M.; Kannenberg J.M.; Huth C.; Meisinger C.; Koenig W.; Heier M.; Peters A.; Rathmann W.; Roden M.; Herder C.; Thorand B.; Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study. Cardiovasc Diabetol 2017,16(1),109","journal-title":"Cardiovasc Diabetol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S1665-2681(19)30761-6","volume":"14","author":"Guti\u00e9rrez-Vidal R.","year":"2015","unstructured":"Guti\u00e9rrez-Vidal R.; Vega-Badillo J.; Reyes-Ferm\u00edn L.M.; Hern\u00e1ndez-P\u00e9rez H.A.; S\u00e1nchez-Mu\u00f1oz F.; L\u00f3pez-\u00c1lvarez G.S.; Larrieta-Carrasco E.; Fern\u00e1ndez-Silva I.; M\u00e9ndez-S\u00e1nchez N.; Tovar A.R.; Villamil-Ram\u00edrez H.; Mej\u00eda-Dom\u00ednguez A.M.; Villarreal-Molina T.; Hern\u00e1ndez-Pando R.; Campos-P\u00e9rez F.; Aguilar-Salinas C.A.; Canizales-Quinteros S.; SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women. Ann Hepatol 2015,14(5),666-674","journal-title":"Ann Hepatol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/liv.12757","volume":"35","author":"Chatani N.","year":"2015","unstructured":"Chatani N.; Kamada Y.; Kizu T.; Ogura S.; Furuta K.; Egawa M.; Hamano M.; Ezaki H.; Kiso S.; Shimono A.; Ouchi N.; Yoshida Y.; Takehara T.; Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver Int 2015,35(8),2017-2026","journal-title":"Liver Int"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3109\/14767058.2015.1052399","volume":"29","author":"Oztas E.","year":"2016","unstructured":"Oztas E.; Ozler S.; Ersoy E.; Ersoy A.O.; Tokmak A.; Ergin M.; Uygur D.; Danisman N.; Prediction of gestational diabetes mellitus by first trimester serum secreted frizzle-related protein-5 levels. J Matern Fetal Neonatal Med 2016,29(9),1515-1519","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"E595","DOI":"10.3390\/ijms20030595","volume":"20","author":"Kimber-Trojnar \u017b.","year":"2019","unstructured":"Kimber-Trojnar \u017b.; Patro-Ma\u0142ysza J.; Trojnar M.; Darmochwa\u0142-Kolarz D.; Oleszczuk J.; Leszczy\u0144ska-Gorzelak B.; Umbilical Cord SFRP5 levels of term newborns in relation to normal and excessive gestational weight gain. Int J Mol Sci 2019,20(3),E595","journal-title":"Int J Mol Sci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1210\/jc.2012-2466","volume":"98","author":"Hu W.","year":"2013","unstructured":"Hu W.; Li L.; Yang M.; Luo X.; Ran W.; Liu D.; Xiong Z.; Liu H.; Yang G.; Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J Clin Endocrinol Metab 2013,98(1),290-298","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Zhang Y.","year":"1994","unstructured":"Zhang Y.; Proenca R.; Maffei M.; Barone M.; Leopold L.; Friedman J.M.; Positional cloning of the mouse obese gene and its human homologue. Nature 1994,372(6505),425-432","journal-title":"Nature"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.peptides.2018.07.008","volume":"107","author":"Christen T.","year":"2018","unstructured":"Christen T.; Trompet S.; Noordam R.; van Klinken J.B.; van Dijk K.W.; Lamb H.J.; Cobbaert C.M.; den Heijer M.; Jazet I.M.; Jukema J.W.; Rosendaal F.R.; de Mutsert R.; Sex differences in body fat distribution are related to sex differences in serum leptin and adiponectin. Peptides 2018,107,25-31","journal-title":"Peptides"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.4049\/jimmunol.172.3.1809","volume":"172","author":"Zarkesh-Esfahani H.","year":"2004","unstructured":"Zarkesh-Esfahani H.; Pockley A.G.; Wu Z.; Hellewell P.G.; Weetman A.P.; Ross R.J.; Leptin indirectly activates human neutrophils via induction of TNF-\u03b1. J Immunol 2004,172(3),1809-1814","journal-title":"J Immunol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnins.2013.00051","volume":"7","author":"Amitani M.","year":"2013","unstructured":"Amitani M.; Asakawa A.; Amitani H.; Inui A.; The role of leptin in the control of insulin-glucose axis. Front Neurosci 2013,7,51","journal-title":"Front Neurosci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/415339a","volume":"415","author":"Minokoshi Y.","year":"2002","unstructured":"Minokoshi Y.; Kim Y.B.; Peroni O.D.; Fryer L.G.; M\u00fcller C.; Carling D.; Kahn B.B.; Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002,415(6869),339-343","journal-title":"Nature"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cca.2019.08.028","volume":"499","author":"Ghasemi A.","year":"2019","unstructured":"Ghasemi A.; Hashemy S.I.; Azimi-Nezhad M.; Dehghani A.; Saeidi J.; Mohtashami M.; The cross-talk between adipokines and miRNAs in health and obesity-mediated diseases. Clin Chim Acta 2019,499,41-53","journal-title":"Clin Chim Acta"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/0092-8674(95)90151-5","volume":"83","author":"Tartaglia L.A.","year":"1995","unstructured":"Tartaglia L.A.; Dembski M.; Weng X.; Deng N.; Culpepper J.; Devos R.; Richards G.J.; Campfield L.A.; Clark F.T.; Deeds J.; Muir C.; Sanker S.; Moriarty A.; Moore K.J.; Smutko J.S.; Mays G.G.; Wool E.A.; Monroe C.A.; Tepper R.I.; Identification and expression cloning of a leptin receptor, OB-R. Cell 1995,83(7),1263-1271","journal-title":"Cell"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nm1195-1155","volume":"1","author":"Maffei M.","year":"1995","unstructured":"Maffei M.; Halaas J.; Ravussin E.; Pratley R.E.; Lee G.H.; Zhang Y.; Fei H.; Kim S.; Lallone R.; Ranganathan S.; Kern P.A.; Friedman J.M.; Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995,1(11),1155-1161","journal-title":"Nat Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","volume":"12","author":"Ferr\u00e9 P.","year":"2010","unstructured":"Ferr\u00e9 P.; Foufelle F.; Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 2010,12(Suppl. 2),83-92","journal-title":"Diabetes Obes Metab"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1053\/jhep.2001.26518","volume":"34","author":"Ikejima K.","year":"2001","unstructured":"Ikejima K.; Honda H.; Yoshikawa M.; Hirose M.; Kitamura T.; Takei Y.; Sato N.; Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001,34(2),288-297","journal-title":"Hepatology"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00125-015-3769-3","volume":"59","author":"Polyzos S.A.","year":"2016","unstructured":"Polyzos S.A.; Aronis K.N.; Kountouras J.; Raptis D.D.; Vasiloglou M.F.; Mantzoros C.S.; Circulating leptin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Diabetologia 2016,59(1),30-43","journal-title":"Diabetologia"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3350\/cmh.2018.0011","volume":"24","author":"Rotundo L.","year":"2018","unstructured":"Rotundo L.; Persaud A.; Feurdean M.; Ahlawat S.; Kim H.S.; The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study. Clin Mol Hepatol 2018,24(4),392-401","journal-title":"Clin Mol Hepatol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"e0142165","DOI":"10.1371\/journal.pone.0142165","volume":"10","author":"Hossain I.A.","year":"2015","unstructured":"Hossain I.A.; Akter S.; Rahman M.K.; Ali L.; Gender specific association of serum leptin and insulinemic indices with non-alcoholic fatty liver disease in prediabetic subjects. PLoS One 2015,10(11),e0142165","journal-title":"PLoS One"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/01.AOG.0000113621.53602.7a","volume":"103","author":"Qiu C.","year":"2004","unstructured":"Qiu C.; Williams M.A.; Vadachkoria S.; Frederick I.O.; Luthy D.A.; Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol 2004,103(3),519-525","journal-title":"Obstet Gynecol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1677\/joe.1.06227","volume":"186","author":"Lappas M.","year":"2005","unstructured":"Lappas M.; Yee K.; Permezel M.; Rice G.E.; Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol 2005,186(3),457-465","journal-title":"J Endocrinol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1507\/endocrj.51.177","volume":"51","author":"Nuamah M.A.","year":"2004","unstructured":"Nuamah M.A.; Yura S.; Sagawa N.; Itoh H.; Mise H.; Korita D.; Kakui K.; Takemura M.; Ogawa Y.; Nakao K.; Fujii S.; Significant increase in maternal plasma leptin concentration in induced delivery: A possible contribution of pro-inflammatory cytokines to placental leptin secretion. Endocr J 2004,51(2),177-187","journal-title":"Endocr J"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12933-016-0492-4","volume":"16","author":"Lekva T.","year":"2017","unstructured":"Lekva T.; Michelsen A.E.; Aukrust P.; Henriksen T.; Bollerslev J.; Ueland T.; Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus. Cardiovasc Diabetol 2017,16(1),5","journal-title":"Cardiovasc Diabetol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1210\/en.2014-1172","volume":"155","author":"Odle A.K.","year":"2014","unstructured":"Odle A.K.; Haney A.; Allensworth-James M.; Akhter N.; Childs G.V.; Adipocyte versus pituitary leptin in the regulation of pituitary hormones: Somatotropes develop normally in the absence of circulating leptin. Endocrinology 2014,155(11),4316-4328","journal-title":"Endocrinology"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.fertnstert.2005.09.065","volume":"85","author":"Budak E.","year":"2006","unstructured":"Budak E.; Fern\u00e1ndez S\u00e1nchez M.; Bellver J.; Cerver\u00f3 A.; Sim\u00f3n C.; Pellicer A.; Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril 2006,85(6),1563-1581","journal-title":"Fertil Steril"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1684\/ecn.2018.0412","volume":"29","author":"Syriou V.","year":"2018","unstructured":"Syriou V.; Papanikolaou D.; Kozyraki A.; Goulis D.G.; Cytokines and male infertility. Eur Cytokine Netw 2018,29(3),73-82","journal-title":"Eur Cytokine Netw"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1210\/jc.82.12.4144","volume":"82","author":"Karlsson C.","year":"1997","unstructured":"Karlsson C.; Lindell K.; Svensson E.; Bergh C.; Lind P.; Billig H.; Carlsson L.M.; Carlsson B.; Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab 1997,82(12),4144-4148","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.84.3.1072","volume":"84","author":"Agarwal S.K.","year":"1999","unstructured":"Agarwal S.K.; Vogel K.; Weitsman S.R.; Magoffin D.A.; Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary. J Clin Endocrinol Metab 1999,84(3),1072-1076","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=117","first-page":"300","volume":"48","author":"Einollahi N.","year":"2010","unstructured":"Einollahi N.; Dashti N.; Nabatchian F.; Serum leptin concentrations during the menstrual cycle in Iranian healthy women. Acta Med Iran 2010,48(5),300-303","journal-title":"Acta Med Iran"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"Steppan C.M.","year":"2001","unstructured":"Steppan C.M.; Bailey S.T.; Bhat S.; Brown E.J.; Banerjee R.R.; Wright C.M.; Patel H.R.; Ahima R.S.; Lazar M.A.; The hormone resistin links obesity to diabetes. Nature 2001,409(6818),307-312","journal-title":"Nature"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1671e9","DOI":"10.2337\/diabetes.53.7.1671","volume":"53","author":"Rajala M.W.","year":"2004","unstructured":"Rajala M.W.; Qi Y.; Patel H.R.; Takahashi N.; Banerjee R.; Pajvani U.B.; Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 2004,53,1671e9","journal-title":"Diabetes"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1055\/a-0637-1975","volume":"50","author":"Mostafazadeh M.","year":"2018","unstructured":"Mostafazadeh M.; Haiaty S.; Rastqar A.; Keshvari M.; Correlation between resistin level and metabolic syndrome component: A review. Horm Metab Res 2018,50(7),521-536","journal-title":"Horm Metab Res"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.2353\/ajpath.2006.060081","volume":"169","author":"Bertolani C.","year":"2006","unstructured":"Bertolani C.; Sancho-Bru P.; Failli P.; Bataller R.; Aleffi S.; DeFranco R.; Mazzinghi B.; Romagnani P.; Milani S.; Gin\u00e9s P.; Colmenero J.; Parola M.; Gelmini S.; Tarquini R.; Laffi G.; Pinzani M.; Marra F.; Resistin as an intrahepatic cytokine: Overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol 2006,169(6),2042-2053","journal-title":"Am J Pathol"},{"key":"ref=122","first-page":"705","volume":"15","author":"Polyzos S.A.","year":"2016","unstructured":"Polyzos S.A.; Kountouras J.; Polymerou V.; Papadimitriou K.G.; Zavos C.; Katsinelos P.; Vaspin, resistin, retinol-binding protein-4, interleukin-1\u03b1 and interleukin-6 in patients with nonalcoholic fatty liver disease. Ann Hepatol 2016,15(5),705-714","journal-title":"Ann Hepatol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/hep.28776","volume":"65","author":"Ajmera V.","year":"2017","unstructured":"Ajmera V.; Perito E.R.; Bass N.M.; Terrault N.A.; Yates K.P.; Gill R.; Loomba R.; Diehl A.M.; Aouizerat B.E.; Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology NASH Clinical Research Network2017,65(1),65-77","journal-title":"Hepatology"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1210\/jc.2002-011926","volume":"88","author":"Yura S.","year":"2003","unstructured":"Yura S.; Sagawa N.; Itoh H.; Kakui K.; Nuamah M.A.; Korita D.; Takemura M.; Fujii S.; Resistin is expressed in the human placenta. J Clin Endocrinol Metab 2003,88(3),1394-1397","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/09513590802653825","volume":"25","author":"Kuzmicki M.","year":"2009","unstructured":"Kuzmicki M.; Telejko B.; Szamatowicz J.; Zonenberg A.; Nikolajuk A.; Kretowski A.; Gorska M.; High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 2009,25(4),258-263","journal-title":"Gynecol Endocrinol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/EJE-07-0671","volume":"158","author":"Megia A.","year":"2008","unstructured":"Megia A.; Vendrell J.; Gutierrez C.; Sabat\u00e9 M.; Broch M.; Fern\u00e1ndez-Real J.M.; Sim\u00f3n I.; Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol 2008,158(2),173-178","journal-title":"Eur J Endocrinol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.fertnstert.2014.04.017","volume":"102","author":"Moretti E.","year":"2014","unstructured":"Moretti E.; Collodel G.; Mazzi L.; Campagna M.; Iacoponi F.; Figura N.; Resistin, interleukin-6, tumor necrosis factor-alpha, and human semen parameters in the presence of leukocytospermia, smoking habit, and varicocele. Fertil Steril 2014,102(2),354-360","journal-title":"Fertil Steril"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1242\/jcs.01196","volume":"117","author":"Nogueiras R.","year":"2004","unstructured":"Nogueiras R.; Barreiro M.L.; Caminos J.E.; Gayt\u00e1n F.; Suominen J.S.; Navarro V.M.; Casanueva F.F.; Aguilar E.; Toppari J.; Di\u00e9guez C.; Tena-Sempere M.; Novel expression of resistin in rat testis: functional role and regulation by nutritional status and hormonal factors. J Cell Sci 2004,117(Pt 15),3247-3257","journal-title":"J Cell Sci"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1210\/jc.2004-2152","volume":"90","author":"Munir I.","year":"2005","unstructured":"Munir I.; Yen H.W.; Baruth T.; Tarkowski R.; Azziz R.; Magoffin D.A.; Jakimiuk A.J.; Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab 2005,90(8),4852-4857","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/19396368.2019.1615151","volume":"65","author":"Messini C.I.","year":"2019","unstructured":"Messini C.I.; Vasilaki A.; Korona E.; Anifandis G.; Georgoulias P.; Dafopoulos K.; Garas A.; Daponte A.; Messinis I.E.; Effect of resistin on estradiol and progesterone secretion from human luteinized granulosa cells in culture. Syst Biol Reprod Med 2019,65(5),350-356","journal-title":"Syst Biol Reprod Med"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/humrep\/deh589","volume":"20","author":"Seow K.M.","year":"2005","unstructured":"Seow K.M.; Juan C.C.; Hsu Y.P.; Ho L.T.; Wang Y.Y.; Hwang J.L.; Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles. Hum Reprod 2005,20(1),117-121","journal-title":"Hum Reprod"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1684\/ecn.2015.0370","volume":"26","author":"Gul O.O.","year":"2015","unstructured":"Gul O.O.; Cander S.; Gul B.; A\u00e7\u0131kgoz E.; Sarandol E.; Ersoy C.; Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome. Eur Cytokine Netw 2015,26(4),73-78","journal-title":"Eur Cytokine Netw"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.clinbiochem.2011.08.1148","volume":"44","author":"Shaker O.","year":"2011","unstructured":"Shaker O.; El-Shehaby A.; Zakaria A.; Mostafa N.; Talaat S.; Katsiki N.; Mikhailidis D.P.; Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver. Clin Biochem 2011,44(17-18),1457-1463","journal-title":"Clin Biochem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","volume":"178","author":"Moschen A.R.","year":"2007","unstructured":"Moschen A.R.; Kaser A.; Enrich B.; Mosheimer B.; Theurl M.; Niederegger H.; Tilg H.; Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007,178(3),1748-1758","journal-title":"J Immunol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/1566524018666180705114131","volume":"18","author":"Kumari B.","year":"2018","unstructured":"Kumari B.; Yadav U.C.S.; Adipokine Visfatin\u2019s role in pathogenesis of diabesity and related metabolic derangements. Curr Mol Med 2018,18(2),116-125","journal-title":"Curr Mol Med"},{"key":"ref=136","first-page":"62","volume":"24","author":"Hameed W.","year":"2012","unstructured":"Hameed W.; Yousaf I.; Latif R.; Aslam M.; Effect of visfatin on testicular steroidogenesis in purified Leydig cells. J Ayub Med Coll Abbottabad 2012,24(3-4),62-64","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.aanat.2017.01.009","volume":"211","author":"Jeremy M.","year":"2017","unstructured":"Jeremy M.; Gurusubramanian G.; Roy V.K.; Localization pattern of visfatin (NAMPT) in d-galactose induced aged rat testis. Ann Anat 2017,211,46-54","journal-title":"Ann Anat"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.fertnstert.2008.12.090","volume":"93","author":"Shen C.J.","year":"2010","unstructured":"Shen C.J.; Tsai E.M.; Lee J.N.; Chen Y.L.; Lee C.H.; Chan T.F.; The concentrations of visfatin in the follicular fluids of women undergoing controlled ovarian stimulation are correlated to the number of oocytes retrieved. Fertil Steril 2010,93(6),1844-1850","journal-title":"Fertil Steril"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.fertnstert.2009.04.055","volume":"94","author":"Plati E.","year":"2010","unstructured":"Plati E.; Kouskouni E.; Malamitsi-Puchner A.; Boutsikou M.; Kaparos G.; Baka S.; Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation. Fertil Steril 2010,94(4),1451-1456","journal-title":"Fertil Steril"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/molehr\/gat002","volume":"19","author":"Reverchon M.","year":"2013","unstructured":"Reverchon M.; Cornuau M.; Cloix L.; Ram\u00e9 C.; Guerif F.; Roy\u00e8re D.; Dupont J.; Visfatin is expressed in human granulosa cells: regulation by metformin through AMPK\/SIRT1 pathways and its role in steroidogenesis. Mol Hum Reprod 2013,19(5),313-326","journal-title":"Mol Hum Reprod"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"34661","DOI":"10.1074\/jbc.M504868200","volume":"280","author":"Zabel B.A.","year":"2005","unstructured":"Zabel B.A.; Allen S.J.; Kulig P.; Allen J.A.; Cichy J.; Handel T.M.; Butcher E.C.; Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 2005,280(41),34661-34666","journal-title":"J Biol Chem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2011.11.004","volume":"22","author":"Bondue B.","year":"2011","unstructured":"Bondue B.; Wittamer V.; Parmentier M.; Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev 2011,22(5-6),331-338","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1084\/jem.20030382","volume":"198","author":"Wittamer V.","year":"2003","unstructured":"Wittamer V.; Franssen J.D.; Vulcano M.; Mirjolet J.F.; Le Poul E.; Migeotte I.; Br\u00e9zillon S.; Tyldesley R.; Blanpain C.; Detheux M.; Mantovani A.; Sozzani S.; Vassart G.; Parmentier M.; Communi D.; Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003,198(7),977-985","journal-title":"J Exp Med"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.4049\/jimmunol.1402166","volume":"194","author":"Herov\u00e1 M.","year":"2015","unstructured":"Herov\u00e1 M.; Schmid M.; Gemperle C.; Hersberger M.; ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages. J Immunol 2015,194(5),2330-2337","journal-title":"J Immunol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/obr.12009","volume":"14","author":"Rourke J.L.","year":"2013","unstructured":"Rourke J.L.; Dranse H.J.; Sinal C.J.; Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes Rev 2013,14(3),245-262","journal-title":"Obes Rev"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/en.2009-1098","volume":"151","author":"Ernst M.C.","year":"2010","unstructured":"Ernst M.C.; Issa M.; Goralski K.B.; Sinal C.J.; Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 2010,151(5),1998-2007","journal-title":"Endocrinology"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1210\/jc.2008-1833","volume":"94","author":"Bozaoglu K.","year":"2009","unstructured":"Bozaoglu K.; Segal D.; Shields K.A.; Cummings N.; Curran J.E.; Comuzzie A.G.; Mahaney M.C.; Rainwater D.L.; VandeBerg J.L.; MacCluer J.W.; Collier G.; Blangero J.; Walder K.; Jowett J.B.; Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 2009,94(8),3085-3088","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"e1990","DOI":"10.1097\/MD.0000000000001990","volume":"94","author":"Lu B.","year":"2015","unstructured":"Lu B.; Zhao M.; Jiang W.; Ma J.; Yang C.; Shao J.; Gu P.; Independent association of circulating level of chemerin with functional and early morphological vascular changes in newly diagnosed Type 2 diabetic patients. Medicine (Baltimore) 2015,94(47),e1990","journal-title":"Medicine (Baltimore)"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/s41366-018-0157-3","volume":"42","author":"Niklowitz P.","year":"2018","unstructured":"Niklowitz P.; Rothermel J.; Lass N.; Barth A.; Reinehr T.; Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: Findings from a longitudinal study in obese children participating in a lifestyle intervention. Int J Obes 2018,42(10),1743-1752","journal-title":"Int J Obes"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.regpep.2012.12.001","volume":"181","author":"Stelmanska E.","year":"2013","unstructured":"Stelmanska E.; Sledzinski T.; Turyn J.; Presler M.; Korczynska J.; Swierczynski J.; Chemerin gene expression is regulated by food restriction and food restriction-refeeding in rat adipose tissue but not in liver. Regul Pept 2013,181,22-29","journal-title":"Regul Pept"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.febslet.2008.01.023","volume":"582","author":"Takahashi M.","year":"2008","unstructured":"Takahashi M.; Takahashi Y.; Takahashi K.; Zolotaryov F.N.; Hong K.S.; Kitazawa R.; Iida K.; Okimura Y.; Kaji H.; Kitazawa S.; Kasuga M.; Chihara K.; Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett 2008,582(5),573-578","journal-title":"FEBS Lett"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/srep00123","volume":"1","author":"Takahashi M.","year":"2011","unstructured":"Takahashi M.; Okimura Y.; Iguchi G.; Nishizawa H.; Yamamoto M.; Suda K.; Kitazawa R.; Fujimoto W.; Takahashi K.; Zolotaryov F.N.; Hong K.S.; Kiyonari H.; Abe T.; Kaji H.; Kitazawa S.; Kasuga M.; Chihara K.; Takahashi Y.; Chemerin regulates \u03b2-cell function in mice. Sci Rep 2011,1,123","journal-title":"Sci Rep"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/EJE-13-0112","volume":"169","author":"D\u00f6cke S.","year":"2013","unstructured":"D\u00f6cke S.; Lock J.F.; Birkenfeld A.L.; Hoppe S.; Lieske S.; Rieger A.; Raschzok N.; Sauer I.M.; Florian S.; Osterhoff M.A.; Heller R.; Herrmann K.; Lindenm\u00fcller S.; Horn P.; Bauer M.; Weickert M.O.; Neuhaus P.; Stockmann M.; M\u00f6hlig M.; Pfeiffer A.F.; von Loeffelholz C.; Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. Eur J Endocrinol 2013,169(5),547-557","journal-title":"Eur J Endocrinol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yexmp.2013.07.009","volume":"95","author":"Krautbauer S.","year":"2013","unstructured":"Krautbauer S.; Wanninger J.; Eisinger K.; Hader Y.; Beck M.; Kopp A.; Schmid A.; Weiss T.S.; Dorn C.; Buechler C.; Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Exp Mol Pathol 2013,95(2),199-205","journal-title":"Exp Mol Pathol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/14767058.2016.1199671","volume":"30","author":"Fatima S.S.","year":"2017","unstructured":"Fatima S.S.; Alam F.; Chaudhry B.; Khan T.A.; Elevated levels of chemerin, leptin, and interleukin-18 in gestational diabetes mellitus. J Matern Fetal Neonatal Med 2017,30(9),1023-1028","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12944-018-0826-1","volume":"17","author":"Zhou Z.","year":"2018","unstructured":"Zhou Z.; Chen H.; Ju H.; Sun M.; Circulating chemerin levels and gestational diabetes mellitus: A systematic review and meta-analysis. Lipids Health Dis 2018,17(1),169","journal-title":"Lipids Health Dis"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/cen.12140","volume":"80","author":"van Poppel M.N.","year":"2014","unstructured":"van Poppel M.N.; Zeck W.; Ulrich D.; Schest E.C.; Hirschmugl B.; Lang U.; Wadsack C.; Desoye G.; Cord blood chemerin: differential effects of gestational diabetes mellitus and maternal obesity. Clin Endocrinol (Oxf) 2014,80(1),65-72","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=158","first-page":"195","volume":"37","author":"Cetin O.","year":"2017","unstructured":"Cetin O.; Kurdoglu Z.; Kurdoglu M.; Sahin H.G.; Chemerin level in pregnancies complicated by preeclampsia and its relation with disease severity and neonatal outcomes. J Obstet Gynaecol 2017,37(2),195-199","journal-title":"J Obstet Gynaecol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mce.2015.03.013","volume":"409","author":"Chen H.","year":"2015","unstructured":"Chen H.; Jin S.; Guo J.; Kombairaju P.; Biswal S.; Zirkin B.R.; Knockout of the transcription factor Nrf2: Effects on testosterone production by aging mouse Leydig cells. Mol Cell Endocrinol 2015,409,113-120","journal-title":"Mol Cell Endocrinol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4103\/aja.aja_25_19","volume":"21","author":"Bongrani A.","year":"2019","unstructured":"Bongrani A.; Elfassy Y.; Brun J.S.; Ram\u00e9 C.; Mellouk N.; Fellahi S.; Bastard J.P.; Levy R.; Vasseur C.; Froment P.; Dupont J.; Expression of adipokines in seminal fluid of men of normal weight. Asian J Androl 2019,21(5),528-530","journal-title":"Asian J Androl"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"28175","DOI":"10.1074\/jbc.M700793200","volume":"282","author":"Goralski K.B.","year":"2007","unstructured":"Goralski K.B.; McCarthy T.C.; Hanniman E.A.; Zabel B.A.; Butcher E.C.; Parlee S.D.; Muruganandan S.; Sinal C.J.; Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007,282(38),28175-28188","journal-title":"J Biol Chem"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.3390\/ijms20153778","volume":"20","author":"Bongrani A.","year":"2019","unstructured":"Bongrani A.; Mellouk N.; Rame C.; Cornuau M.; Gu\u00e9rif F.; Froment P.; Dupont J.; Ovarian expression of adipokines in polycystic ovary syndrome: A role for chemerin, omentin, and apelin in follicular growth arrest and ovulatory dysfunction? Int J Mol Sci 2019,20(15),3778","journal-title":"Int J Mol Sci"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/humrep\/des089","volume":"27","author":"Reverchon M.","year":"2012","unstructured":"Reverchon M.; Cornuau M.; Ram\u00e9 C.; Guerif F.; Roy\u00e8re D.; Dupont J.; Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells. Hum Reprod 2012,27(6),1790-1800","journal-title":"Hum Reprod"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1210\/en.2004-1427","volume":"146","author":"Boucher J.","year":"2005","unstructured":"Boucher J.; Masri B.; Daviaud D.; Gesta S.; Guign\u00e9 C.; Mazzucotelli A.; Castan-Laurell I.; Tack I.; Knibiehler B.; Carp\u00e9n\u00e9 C.; Audigier Y.; Saulnier-Blache J.S.; Valet P.; Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005,146(4),1764-1771","journal-title":"Endocrinology"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"e86577","DOI":"10.1371\/journal.pone.0086577","volume":"9","author":"Ba H.J.","year":"2014","unstructured":"Ba H.J.; Chen H.S.; Su Z.; Du M.L.; Chen Q.L.; Li Y.H.; Ma H.M.; Associations between serum apelin-12 levels and obesity-related markers in Chinese children. PLoS One 2014,9(1),e86577","journal-title":"PLoS One"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000348667","volume":"6","author":"Krist J.","year":"2013","unstructured":"Krist J.; Wieder K.; Kl\u00f6ting N.; Oberbach A.; Kralisch S.; Wiesner T.; Sch\u00f6n M.R.; G\u00e4rtner D.; Dietrich A.; Shang E.; Lohmann T.; Dre\u00dfler M.; Fasshauer M.; Stumvoll M.; Bl\u00fcher M.; Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts 2013,6(1),57-69","journal-title":"Obes Facts"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.peptides.2013.05.013","volume":"46","author":"Butruille L.","year":"2013","unstructured":"Butruille L.; Drougard A.; Knauf C.; Moitrot E.; Valet P.; Storme L.; Deruelle P.; Lesage J.; The apelinergic system: sexual dimorphism and tissue-specific modulations by obesity and insulin resistance in female mice. Peptides 2013,46,94-101","journal-title":"Peptides"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.regpep.2005.05.004","volume":"131","author":"S\u00f6rhede Winzell M.","year":"2005","unstructured":"S\u00f6rhede Winzell M.; Magnusson C.; Ahr\u00e9n B.; The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 2005,131(1-3),12-17","journal-title":"Regul Pept"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.mce.2012.07.002","volume":"362","author":"Than A.","year":"2012","unstructured":"Than A.; Cheng Y.; Foh L.C.; Leow M.K.; Lim S.C.; Chuah Y.J.; Kang Y.; Chen P.; Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways. Mol Cell Endocrinol 2012,362(1-2),227-241","journal-title":"Mol Cell Endocrinol"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"14679","DOI":"10.1074\/jbc.M115.643817","volume":"290","author":"Than A.","year":"2015","unstructured":"Than A.; He H.L.; Chua S.H.; Xu D.; Sun L.; Leow M.K.; Chen P.; Apelin enhances brown adipogenesis and browning of white adipocytes. J Biol Chem 2015,290(23),14679-14691","journal-title":"J Biol Chem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11010-019-03581-0","volume":"460","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Song J.; Bian H.; Bo J.; Lv S.; Pan W.; Lv X.; Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells. Mol Cell Biochem 2019,460(1-2),205-215","journal-title":"Mol Cell Biochem"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/jrms.JRMS_788_16","volume":"22","author":"Montazerifar F.","year":"2017","unstructured":"Montazerifar F.; Bakhshipour A.R.; Karajibani M.; Torki Z.; Dashipour A.R.; Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease. J Res Med Sci 2017,22,70","journal-title":"J Res Med Sci"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"112145","DOI":"10.18632\/oncotarget.22841","volume":"8","author":"Lv S.Y.","year":"2017","unstructured":"Lv S.Y.; Cui B.; Chen W.D.; Wang Y.D.; Apelin\/APJ system: A key therapeutic target for liver disease. Oncotarget 2017,8(67),112145-112151","journal-title":"Oncotarget"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.diabres.2009.10.018","volume":"87","author":"Telejko B.","year":"2010","unstructured":"Telejko B.; Kuzmicki M.; Wawrusiewicz-Kurylonek N.; Szamatowicz J.; Nikolajuk A.; Zonenberg A.; Zwierz-Gugala D.; Jelski W.; Lauda\u0144ski P.; Wilczynski J.; Kretowski A.; Gorska M.; Plasma apelin levels and apelin\/APJ mRNA expression in patients with gestational diabetes mellitus. Diabetes Res Clin Pract 2010,87(2),176-183","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12020-011-9577-8","volume":"41","author":"Aslan M.","year":"2012","unstructured":"Aslan M.; Celik O.; Celik N.; Turkcuoglu I.; Yilmaz E.; Karaer A.; Simsek Y.; Celik E.; Aydin S.; Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 2012,41(3),424-429","journal-title":"Endocrine"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neulet.2015.06.059","volume":"602","author":"Sandal S.","year":"2015","unstructured":"Sandal S.; Tekin S.; Seker F.B.; Beytur A.; Vardi N.; Colak C.; Tapan T.; Yildiz S.; Yilmaz B.; The effects of intracerebroventricular infusion of apelin-13 on reproductive function in male rats. Neurosci Lett 2015,602,133-138","journal-title":"Neurosci Lett"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejogrb.2014.02.022","volume":"176","author":"Altinkaya S.O.","year":"2014","unstructured":"Altinkaya S.O.; Nergiz S.; K\u00fc\u00e7\u00fck M.; Y\u00fcksel H.; Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2014,176,168-172","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1016\/j.fertnstert.2011.04.044","volume":"95","author":"Chang C.Y.","year":"2011","unstructured":"Chang C.Y.; Tsai Y.C.; Lee C.H.; Chan T.F.; Wang S.H.; Su J.H.; Lower serum apelin levels in women with polycystic ovary syndrome. Fertil Steril 2011,95(8),2520-3.e1-2","journal-title":"Fertil Steril"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1095\/biolreprod.116.141754","volume":"95","author":"Roche J.","year":"2016","unstructured":"Roche J.; Ram\u00e9 C.; Reverchon M.; Mellouk N.; Cornuau M.; Guerif F.; Froment P.; Dupont J.; Apelin (APLN) and Apelin Receptor (APLNR) in human ovary: Expression, signaling, and regulation of steroidogenesis in primary human luteinized granulosa cells. Biol Reprod 2016,95(5),104","journal-title":"Biol Reprod"},{"key":"ref=180","first-page":"50","volume":"14","author":"Ozkan Z.S.","year":"2013","unstructured":"Ozkan Z.S.; Cilgin H.; Simsek M.; Cobanoglu B.; Ilhan N.; Investigation of apelin expression in endometriosis. J Reprod Infertil 2013,14(2),50-55","journal-title":"J Reprod Infertil"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.dsx.2019.06.005","volume":"13","author":"Kumari R.","year":"2019","unstructured":"Kumari R.; Kumar S.; Kant R.; An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome. Diabetes Metab Syndr 2019,13(4),2409-2417","journal-title":"Diabetes Metab Syndr"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1172\/JCI117495","volume":"94","author":"Hotamisligil G.S.","year":"1994","unstructured":"Hotamisligil G.S.; Budavari A.; Murray D.; Spiegelman B.M.; Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-\u03b1. J Clin Invest 1994,94(4),1543-1549","journal-title":"J Clin Invest"},{"key":"ref=183","first-page":"183e90","volume":"11","author":"Cai D.","year":"2005","unstructured":"Cai D.; Yuan M.; Frantz DF.; Melendez PA.; Hansen L.; Lee J.; Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NFkappaB. Nat Med 2005,11,183e90","journal-title":"Nat Med"},{"key":"ref=184","doi-asserted-by":"crossref","first-page":"117e31","DOI":"10.1016\/j.febslet.2007.11.051","volume":"582","author":"Cawthorn WP.","year":"2008","unstructured":"Cawthorn WP.; Sethi JK.; TNF-alpha and adipocyte biology. FEBS Lett 2008,582,117e31","journal-title":"FEBS Lett"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1271e8","DOI":"10.2337\/diabetes.43.11.1271","volume":"43","author":"Hotamisligil GS.","year":"1994","unstructured":"Hotamisligil GS.; Spiegelman BM.; Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994,43,1271e8","journal-title":"Diabetes"},{"key":"ref=186","doi-asserted-by":"crossref","first-page":"1077e86","DOI":"10.1002\/jcb.10565","volume":"89","author":"Souza SC.","year":"2003","unstructured":"Souza SC.; Palmer HJ.; Kang YH.; Yamamoto MT.; Muliro KV.; Paulson KE.; TNF\u03b1 induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. J Cell Biochem 2003,89,1077e86","journal-title":"J Cell Biochem"},{"key":"ref=187","author":"Fasshauer M.","unstructured":"Fasshauer M.; Klein J.; Neumann S.; Eszlinger M.; Paschke R.; Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2001, 288(4), 1027e31.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=188","author":"Uysal KT.","unstructured":"Uysal KT.; Wiesbrock SM.; Marino MW.; Hotamisligil GS.;  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature, 1997, 389, 610\u2013614."},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000088261","volume":"42","author":"Dominguez H.","year":"2005","unstructured":"Dominguez H.; Storgaard H.; Rask-Madsen C.; Steffen Hermann T.; Ihlemann N.; Baunbjerg Nielsen D.; Spohr C.; Kober L.; Vaag A.; Torp-Pedersen C.; Metabolic and vascular effects of tumor necrosis factor-\u03b1 blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res 2005,42(6),517-525","journal-title":"J Vasc Res"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"1495e8","DOI":"10.1007\/s10067-007-0539-8","volume":"26","author":"Tam LS.","year":"2007","unstructured":"Tam LS.; Tomlinson B.; Chu TT.; Li T.; Li EK.; Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 2007,26,1495e8","journal-title":"Clin Rheumatol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","volume":"343","author":"Tilg H.","year":"2000","unstructured":"Tilg H.; Diehl A.M.; Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000,343(20),1467-1476","journal-title":"N Engl J Med"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"Tilg H.","year":"2017","unstructured":"Tilg H.; Moschen A.R.; Roden M.; NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol 2017,14(1),32-42","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1530\/REP-16-0495","volume":"153","author":"Howell K.R.","year":"2017","unstructured":"Howell K.R.; Powell T.L.; Effects of maternal obesity on placental function and fetal development. Reproduction 2017,153(3),R97-R108","journal-title":"Reproduction"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"926932","DOI":"10.1155\/2014\/926932","volume":"2014","author":"Xu J.","year":"2014","unstructured":"Xu J.; Zhao Y.H.; Chen Y.P.; Yuan X.L.; Wang J.; Zhu H.; Lu C.M.; Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: A systematic review and meta-analysis. ScientificWorldJournal 2014,2014,926932","journal-title":"ScientificWorldJournal"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.2337\/dc07-s202","volume":"30","author":"Barbour L.A.","year":"2007","unstructured":"Barbour L.A.; McCurdy C.E.; Hernandez T.L.; Kirwan J.P.; Catalano P.M.; Friedman J.E.; Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007,30(Suppl. 2),S112-S119","journal-title":"Diabetes Care"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1128\/MCB.24.7.2593-2604.2004","volume":"24","author":"Hong C.Y.","year":"2004","unstructured":"Hong C.Y.; Park J.H.; Ahn R.S.; Im S.Y.; Choi H.S.; Soh J.; Mellon S.H.; Lee K.; Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor \u03b1. Mol Cell Biol 2004,24(7),2593-2604","journal-title":"Mol Cell Biol"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1210\/endo.139.6.6077","volume":"139","author":"Mauduit C.","year":"1998","unstructured":"Mauduit C.; Gasnier F.; Rey C.; Chauvin M.A.; Stocco D.M.; Louisot P.; Benahmed M.; Tumor necrosis factor-alpha inhibits leydig cell steroidogenesis through a decrease in steroidogenic acute regulatory protein expression. Endocrinology 1998,139(6),2863-2868","journal-title":"Endocrinology"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1210\/en.2003-0569","volume":"144","author":"Morales V.","year":"2003","unstructured":"Morales V.; Santana P.; D\u00edaz R.; Tabraue C.; Gallardo G.; L\u00f3pez Blanco F.; Hern\u00e1ndez I.; Fanjul L.F.; Ruiz de Galarreta C.M.; Intratesticular delivery of tumor necrosis factor-alpha and ceramide directly abrogates steroidogenic acute regulatory protein expression and Leydig cell steroidogenesis in adult rats. Endocrinology 2003,144(11),4763-4772","journal-title":"Endocrinology"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.fertnstert.2012.04.008","volume":"98","author":"Wu L.","year":"2012","unstructured":"Wu L.; Zhang A.; Sun Y.; Zhu X.; Fan W.; Lu X.; Yang Q.; Feng Y.; Sirt1 exerts anti-inflammatory effects and promotes steroidogenesis in Leydig cells. Fertil Steril 2012,98(1),194-199","journal-title":"Fertil Steril"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1210\/endo.132.6.8504748","volume":"132","author":"Xiong Y.","year":"1993","unstructured":"Xiong Y.; Hales D.B.; The role of tumor necrosis factor-alpha in the regulation of mouse Leydig cell steroidogenesis. Endocrinology 1993,132(6),2438-2444","journal-title":"Endocrinology"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12958-018-0341-2","volume":"16","author":"Leisegang K.","year":"2018","unstructured":"Leisegang K.; Henkel R.; The in vitro modulation of steroidogenesis by inflammatory cytokines and insulin in TM3 Leydig cells. Reprod Biol Endocrinol 2018,16(1),26","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1262\/jrd.49.441","volume":"49","author":"Sakumoto R.","year":"2003","unstructured":"Sakumoto R.; Shibaya M.; Okuda K.; Tumor necrosis factor-\u03b1 (TNF \u03b1) inhibits progesterone and estradiol-17\u03b2 production from cultured granulosa cells: Presence of TNFalpha receptors in bovine granulosa and theca cells. J Reprod Dev 2003,49(6),441-449","journal-title":"J Reprod Dev"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1095\/biolreprod65.3.928","volume":"65","author":"Prange-Kiel J.","year":"2001","unstructured":"Prange-Kiel J.; Kreutzkamm C.; Wehrenberg U.; Rune G.M.; Role of tumor necrosis factor in preovulatory follicles of swine. Biol Reprod 2001,65(3),928-935","journal-title":"Biol Reprod"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1095\/biolreprod61.6.1506","volume":"61","author":"Balchak S.K.","year":"1999","unstructured":"Balchak S.K.; Marcinkiewicz J.L.; Evidence for the presence of tumor necrosis factor alpha receptors during ovarian development in the rat. Biol Reprod 1999,61(6),1506-1512","journal-title":"Biol Reprod"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1385\/ENDO:8:2:109","volume":"8","author":"Spicer L.J.","year":"1998","unstructured":"Spicer L.J.; Tumor necrosis factor-\u03b1 (TNF-\u03b1) inhibits steroidogenesis of bovine ovarian granulosa and thecal cells in vitro. Involvement of TNF-\u03b1 receptors. Endocrine 1998,8(2),109-115","journal-title":"Endocrine"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1046\/j.1439-0531.2002.00324.x","volume":"37","author":"Miyamoto Y.","year":"2002","unstructured":"Miyamoto Y.; Sakumoto R.; Sakabe Y.; Miyake M.; Okano A.; Okuda K.; Tumour necrosis factor-\u03b1 receptors are present in the corpus luteum throughout the oestrous cycle and during the early gestation period in pigs. Reprod Domest Anim 2002,37(2),105-110","journal-title":"Reprod Domest Anim"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1262\/jrd.50.39","volume":"50","author":"Sakumoto R.","year":"2004","unstructured":"Sakumoto R.; Okuda K.; Possible actions of tumor necrosis factor-\u03b1 in ovarian function. J Reprod Dev 2004,50(1),39-46","journal-title":"J Reprod Dev"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1530\/jrf.0.1150087","volume":"115","author":"Penny L.A.","year":"1999","unstructured":"Penny L.A.; Armstrong D.; Bramley T.A.; Webb R.; Collins R.A.; Watson E.D.; Immune cells and cytokine production in the bovine corpus luteum throughout the oestrous cycle and after induced luteolysis. J Reprod Fertil 1999,115(1),87-96","journal-title":"J Reprod Fertil"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1095\/biolreprod50.1.10","volume":"50","author":"Hehnke K.E.","year":"1994","unstructured":"Hehnke K.E.; Christenson L.K.; Ford S.P.; Taylor M.; Macrophage infiltration into the porcine corpus luteum during prostaglandin F2 \u03b1-induced luteolysis. Biol Reprod 1994,50(1),10-15","journal-title":"Biol Reprod"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1095\/biolreprod56.5.1175","volume":"56","author":"Naftalin D.M.","year":"1997","unstructured":"Naftalin D.M.; Bove S.E.; Keyes P.L.; Townson D.H.; Estrogen withdrawal induces macrophage invasion in the rabbit corpus luteum. Biol Reprod 1997,56(5),1175-1180","journal-title":"Biol Reprod"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/rda.13199","volume":"53","author":"Paulino L.R.F.M.","year":"2018","unstructured":"Paulino L.R.F.M.; Cunha E.V.; Barbalho Silva A.W.; Souza G.B.; Lopes E.P.F.; Donato M.A.M.; Peixoto C.A.; Matos-Brito B.G.; van den Hurk R.; Silva J.R.V.; Effects of tumour necrosis factor-alpha and interleukin-1 beta on in vitro development of bovine secondary follicles. Reprod Domest Anim 2018,53(4),997-1005","journal-title":"Reprod Domest Anim"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"Kimura A.","year":"2010","unstructured":"Kimura A.; Kishimoto T.; IL-6: regulator of Treg\/Th17 balance. Eur J Immunol 2010,40(7),1830-1835","journal-title":"Eur J Immunol"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"Scheller J.","year":"2011","unstructured":"Scheller J.; Chalaris A.; Schmidt-Arras D.; Rose-John S.; The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011,1813(5),878-888","journal-title":"Biochim Biophys Acta"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"4196e200","DOI":"10.1210\/jc.82.12.4196","volume":"82","author":"Mohamed-Ali V.","year":"1997","unstructured":"Mohamed-Ali V.; Goodrick S.; Rawesh A.; Katz DR.; Miles JM.; Yudkin JS.; Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-a, in vivo. J Clin Endocrinol Metab 1997,82,4196e200","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1210\/jc.83.3.847","volume":"83","author":"Fried S.K.","year":"1998","unstructured":"Fried S.K.; Bunkin D.A.; Greenberg A.S.; Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998,83(3),847-850","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1073\/pnas.1920004117","volume":"117","author":"Han M.S.","year":"2020","unstructured":"Han M.S.; White A.; Perry R.J.; Camporez J.P.; Hidalgo J.; Shulman G.I.; Davis R.J.; Regulation of adipose tissue inflammation by interleukin 6. Proc Natl Acad Sci USA 2020,117(6),2751-2760","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1161\/hc0702.104279","volume":"105","author":"Ziccardi P.","year":"2002","unstructured":"Ziccardi P.; Nappo F.; Giugliano G.; Esposito K.; Marfella R.; Cioffi M.; D\u2019Andrea F.; Molinari A.M.; Giugliano D.; Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002,105(7),804-809","journal-title":"Circulation"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"Pradhan A.D.","year":"2001","unstructured":"Pradhan A.D.; Manson J.E.; Rifai N.; Buring J.E.; Ridker P.M.; C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001,286(3),327-334","journal-title":"JAMA"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00125-010-1865-y","volume":"53","author":"Matthews V.B.","year":"2010","unstructured":"Matthews V.B.; Allen T.L.; Risis S.; Chan M.H.; Henstridge D.C.; Watson N.; Zaffino L.A.; Babb J.R.; Boon J.; Meikle P.J.; Jowett J.B.; Watt M.J.; Jansson J.O.; Bruce C.R.; Febbraio M.A.; Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 2010,53(11),2431-2441","journal-title":"Diabetologia"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1126\/science.1160794","volume":"322","author":"Sabio G.","year":"2008","unstructured":"Sabio G.; Das M.; Mora A.; Zhang Z.; Jun J.Y.; Ko H.J.; Barrett T.; Kim J.K.; Davis R.J.; A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 2008,322(5907),1539-1543","journal-title":"Science"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/hep.21087","volume":"43","author":"Jin X.","year":"2006","unstructured":"Jin X.; Zimmers T.A.; Perez E.A.; Pierce R.H.; Zhang Z.; Koniaris L.G.; Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology 2006,43(3),474-484","journal-title":"Hepatology"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"18070","DOI":"10.3748\/wjg.v20.i48.18070","volume":"20","author":"Stojsavljevi\u0107 S.","year":"2014","unstructured":"Stojsavljevi\u0107 S.; Gomer\u010di\u0107 Pal\u010di\u0107 M.; Virovi\u0107 Juki\u0107 L.; Smir\u010di\u0107 Duvnjak L.; Duvnjak M.; Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014,20(48),18070-18091","journal-title":"World J Gastroenterol"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"e12594","DOI":"10.14814\/phy2.12594","volume":"3","author":"Aye I.L.","year":"2015","unstructured":"Aye I.L.; Jansson T.; Powell T.L.; TNF-\u03b1 stimulates System A amino acid transport in primary human trophoblast cells mediated by p38 MAPK signaling. Physiol Rep 2015,3(10),e12594","journal-title":"Physiol Rep"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.placenta.2010.10.012","volume":"32","author":"Lager S.","year":"2011","unstructured":"Lager S.; Jansson N.; Olsson A.L.; Wennergren M.; Jansson T.; Powell T.L.; Effect of IL-6 and TNF-\u03b1 on fatty acid uptake in cultured human primary trophoblast cells. Placenta 2011,32(2),121-127","journal-title":"Placenta"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1600-0412.2011.01094.x","volume":"90","author":"Morisset A.S.","year":"2011","unstructured":"Morisset A.S.; Dub\u00e9 M.C.; C\u00f4t\u00e9 J.A.; Robitaille J.; Weisnagel S.J.; Tchernof A.; Circulating interleukin-6 concentrations during and after gestational diabetes mellitus. Acta Obstet Gynecol Scand 2011,90(5),524-530","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.mce.2009.08.002","volume":"314","author":"Kleiblova P.","year":"2010","unstructured":"Kleiblova P.; Dostalova I.; Bartlova M.; Lacinova Z.; Ticha I.; Krejci V.; Springer D.; Kleibl Z.; Haluzik M.; Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus. Mol Cell Endocrinol 2010,314(1),150-156","journal-title":"Mol Cell Endocrinol"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.placenta.2015.04.006","volume":"36","author":"Pantham P.","year":"2015","unstructured":"Pantham P.; Aye I.L.; Powell T.L.; Inflammation in maternal obesity and gestational diabetes mellitus. Placenta 2015,36(7),709-715","journal-title":"Placenta"},{"key":"ref=228","first-page":"84","volume":"24","author":"Watson M.E.","year":"1994","unstructured":"Watson M.E.; Newman R.J.; Payne A.M.; Abdelrahim M.; Francis G.L.; The effect of macrophage conditioned media on Leydig cell function. Ann Clin Lab Sci 1994,24(1),84-95","journal-title":"Ann Clin Lab Sci"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1089\/107999099312948","volume":"19","author":"Tsigos C.","year":"1999","unstructured":"Tsigos C.; Papanicolaou D.A.; Kyrou I.; Raptis S.A.; Chrousos G.P.; Dose-dependent effects of recombinant human interleukin-6 on the pituitary-testicular axis. J Interferon Cytokine Res 1999,19(11),1271-1276","journal-title":"J Interferon Cytokine Res"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF02738619","volume":"10","author":"Hales D.B.","year":"1999","unstructured":"Hales D.B.; Diemer T.; Hales K.H.; Role of cytokines in testicular function. Endocrine 1999,10(3),201-217","journal-title":"Endocrine"},{"key":"ref=231","first-page":"654","volume":"80","author":"Pasquali R.","year":"1995","unstructured":"Pasquali R.; Casimirri F.; De Iasio R.; Mesini P.; Boschi S.; Chierici R.; Flamia R.; Biscotti M.; Vicennati V.; Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab 1995,80(2),654-658","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"E206","DOI":"10.1152\/ajpendo.00279.2017","volume":"314","author":"Tremellen K.","year":"2018","unstructured":"Tremellen K.; McPhee N.; Pearce K.; Benson S.; Schedlowski M.; Engler H.; Endotoxin-initiated inflammation reduces testosterone production in men of reproductive age. Am J Physiol Endocrinol Metab 2018,314(3),E206-E213","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1210\/jc.82.7.2343","volume":"82","author":"P\u00e4th G.","year":"1997","unstructured":"P\u00e4th G.; Bornstein S.R.; Ehrhart-Bornstein M.; Scherbaum W.A.; Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. J Clin Endocrinol Metab 1997,82(7),2343-2349","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.mce.2003.11.022","volume":"215","author":"Bornstein S.R.","year":"2004","unstructured":"Bornstein S.R.; Rutkowski H.; Vrezas I.; Cytokines and steroidogenesis. Mol Cell Endocrinol 2004,215(1-2),135-141","journal-title":"Mol Cell Endocrinol"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1210\/endo.136.12.7588304","volume":"136","author":"Taylor C.C.","year":"1995","unstructured":"Taylor C.C.; Terranova P.F.; Lipopolysaccharide inhibits rat ovarian thecal-interstitial cell steroid secretion in vitro. Endocrinology 1995,136(12),5527-5532","journal-title":"Endocrinology"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1210\/en.2008-1532","volume":"150","author":"Liu Z.","year":"2009","unstructured":"Liu Z.; de Matos D.G.; Fan H.Y.; Shimada M.; Palmer S.; Richards J.S.; Interleukin-6: An autocrine regulator of the mouse cumulus cell-oocyte complex expansion process. Endocrinology 2009,150(7),3360-3368","journal-title":"Endocrinology"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1210\/en.2011-1124","volume":"152","author":"Bromfield J.J.","year":"2011","unstructured":"Bromfield J.J.; Sheldon I.M.; Lipopolysaccharide initiates inflammation in bovine granulosa cells via the TLR4 pathway and perturbs oocyte meiotic progression in vitro. Endocrinology 2011,152(12),5029-5040","journal-title":"Endocrinology"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/REP-17-0053","volume":"154","author":"Samir M.","year":"2017","unstructured":"Samir M.; Glister C.; Mattar D.; Laird M.; Knight P.G.; Follicular expression of pro-inflammatory cytokines tumour necrosis factor-\u03b1 (TNF\u03b1), interleukin 6 (IL6) and their receptors in cattle: TNF\u03b1, IL6 and macrophages suppress thecal androgen production in vitro. Reproduction 2017,154(1),35-49","journal-title":"Reproduction"},{"key":"ref=239","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","volume":"268","author":"Kjeldsen L.","year":"1993","unstructured":"Kjeldsen L.; Johnsen A.H.; Sengel\u00f8v H.; Borregaard N.; Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993,268(14),10425-10432","journal-title":"J Biol Chem"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.4049\/jimmunol.176.9.5559","volume":"176","author":"Cowland J.B.","year":"2006","unstructured":"Cowland J.B.; Muta T.; Borregaard N.; IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J Immunol 2006,176(9),5559-5566","journal-title":"J Immunol"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1210\/me.2007-0420","volume":"22","author":"Zhang J.","year":"2008","unstructured":"Zhang J.; Wu Y.; Zhang Y.; Leroith D.; Bernlohr D.A.; Chen X.; The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 2008,22(6),1416-1426","journal-title":"Mol Endocrinol"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"e96997","DOI":"10.1371\/journal.pone.0096997","volume":"9","author":"Zhang Y.","year":"2014","unstructured":"Zhang Y.; Foncea R.; Deis J.A.; Guo H.; Bernlohr D.A.; Chen X.; Lipocalin 2 expression and secretion is highly regulated by metabolic stress, cytokines, and nutrients in adipocytes. PLoS One 2014,9(5),e96997","journal-title":"PLoS One"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2337\/db07-0007","volume":"56","author":"Yan Q.W.","year":"2007","unstructured":"Yan Q.W.; Yang Q.; Mody N.; Graham T.E.; Hsu C.H.; Xu Z.; Houstis N.E.; Kahn B.B.; Rosen E.D.; The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007,56(10),2533-2540","journal-title":"Diabetes"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"22063","DOI":"10.1074\/jbc.M114.559104","volume":"289","author":"Zhang Y.","year":"2014","unstructured":"Zhang Y.; Guo H.; Deis J.A.; Mashek M.G.; Zhao M.; Ariyakumar D.; Armien A.G.; Bernlohr D.A.; Mashek D.G.; Chen X.; Lipocalin 2 regulates brown fat activation via a nonadrenergic activation mechanism. J Biol Chem 2014,289(32),22063-22077","journal-title":"J Biol Chem"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/oby.2011.61","volume":"19","author":"Auguet T.","year":"2011","unstructured":"Auguet T.; Quintero Y.; Terra X.; Mart\u00ednez S.; Lucas A.; Pellitero S.; Aguilar C.; Hern\u00e1ndez M.; del Castillo D.; Richart C.; Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines. Obesity (Silver Spring) 2011,19(12),2295-2300","journal-title":"Obesity (Silver Spring)"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13104-017-2604-y","volume":"10","author":"Elkhidir A.E.","year":"2017","unstructured":"Elkhidir A.E.; Eltaher H.B.; Mohamed A.O.; Association of lipocalin-2 level, glycemic status and obesity in type 2 diabetes mellitus. BMC Res Notes 2017,10(1),285","journal-title":"BMC Res Notes"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2337\/db09-1541","volume":"59","author":"Law I.K.","year":"2010","unstructured":"Law I.K.; Xu A.; Lam K.S.; Berger T.; Mak T.W.; Vanhoutte P.M.; Liu J.T.; Sweeney G.; Zhou M.; Yang B.; Wang Y.; Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 2010,59(4),872-882","journal-title":"Diabetes"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2337\/db09-1735","volume":"59","author":"Guo H.","year":"2010","unstructured":"Guo H.; Jin D.; Zhang Y.; Wright W.; Bazuine M.; Brockman D.A.; Bernlohr D.A.; Chen X.; Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 2010,59(6),1376-1385","journal-title":"Diabetes"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.diabres.2014.08.026","volume":"106","author":"Wu C.","year":"2014","unstructured":"Wu C.; Wang Q.; Lv C.; Qin N.; Lei S.; Yuan Q.; Wang G.; The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. Diabetes Res Clin Pract 2014,106(2),343-350","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1530\/EJE-11-0660","volume":"165","author":"Liu X.","year":"2011","unstructured":"Liu X.; Hamnvik O.P.; Petrou M.; Gong H.; Chamberland J.P.; Christophi C.A.; Kales S.N.; Christiani D.C.; Mantzoros C.S.; Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study. Eur J Endocrinol 2011,165(5),805-812","journal-title":"Eur J Endocrinol"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jhep.2016.05.041","volume":"65","author":"Ye D.","year":"2016","unstructured":"Ye D.; Yang K.; Zang S.; Lin Z.; Chau H.T.; Wang Y.; Zhang J.; Shi J.; Xu A.; Lin S.; Wang Y.; Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2. J Hepatol 2016,65(5),988-997","journal-title":"J Hepatol"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","volume":"28","author":"Moschen A.R.","year":"2017","unstructured":"Moschen A.R.; Adolph T.E.; Gerner R.R.; Wieser V.; Tilg H.; Lipocalin-2: A master mediator of intestinal and metabolic inflammation. Trends Endocrinol Metab 2017,28(5),388-397","journal-title":"Trends Endocrinol Metab"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.diabres.2014.01.014","volume":"104","author":"Lou Y.","year":"2014","unstructured":"Lou Y.; Wu C.; Wu M.; Xie C.; Ren L.; The changes of neutrophil gelatinase-associated lipocalin in plasma and its expression in adipose tissue in pregnant women with gestational diabetes. Diabetes Res Clin Pract 2014,104(1),136-142","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000486853","volume":"45","author":"Sweeting A.N.","year":"2019","unstructured":"Sweeting A.N.; Wong J.; Appelblom H.; Ross G.P.; Kouru H.; Williams P.F.; Sairanen M.; Hyett J.A.; A novel early pregnancy risk prediction model for gestational diabetes mellitus. Fetal Diagn Ther 2019,45(2),76-84","journal-title":"Fetal Diagn Ther"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/19396368.2017.1355416","volume":"63","author":"Kang Z.","year":"2017","unstructured":"Kang Z.; Qiao N.; Tan Z.; Tang Z.; Li Y.; Expression patterns and changes of the LCN2 gene in the testes of induced cryptorchidism and busulfan-treated mice. Syst Biol Reprod Med 2017,63(6),364-369","journal-title":"Syst Biol Reprod Med"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molmet.2019.09.009","volume":"30","author":"Chella Krishnan K.","year":"2019","unstructured":"Chella Krishnan K.; Sabir S.; Shum M.; Meng Y.; Ac\u00edn-P\u00e9rez R.; Lang J.M.; Floyd R.R.; Vergnes L.; Seldin M.M.; Fuqua B.K.; Jayasekera D.W.; Nand S.K.; Anum D.C.; Pan C.; Stiles L.; P\u00e9terfy M.; Reue K.; Liesa M.; Lusis A.J.; Sex-specific metabolic functions of adipose Lipocalin-2. Mol Metab 2019,30,30-47","journal-title":"Mol Metab"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","volume":"115","author":"Xu A.","year":"2007","unstructured":"Xu A.; Tso A.W.; Cheung B.M.; Wang Y.; Wat N.M.; Fong C.H.; Yeung D.C.; Janus E.D.; Sham P.C.; Lam K.S.; Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007,115(12),1537-1543","journal-title":"Circulation"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"e002545","DOI":"10.1161\/JAHA.115.002545","volume":"5","author":"Lee J.J.","year":"2016","unstructured":"Lee J.J.; Pedley A.; Hoffmann U.; Massaro J.M.; Keaney J.F.; Vasan R.S.; Fox C.S.; Cross-sectional associations of computed tomography (CT)-derived adipose tissue density and adipokines: The framingham heart study. J Am Heart Assoc 2016,5(3),e002545","journal-title":"J Am Heart Assoc"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S2213-8587(13)70176-1","volume":"2","author":"Fasshauer M.","year":"2014","unstructured":"Fasshauer M.; Bl\u00fcher M.; Stumvoll M.; Adipokines in gestational diabetes. Lancet Diabetes Endocrinol 2014,2(6),488-499","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"10610","DOI":"10.1073\/pnas.0504703102","volume":"102","author":"Hida K.","year":"2005","unstructured":"Hida K.; Wada J.; Eguchi J.; Zhang H.; Baba M.; Seida A.; Hashimoto I.; Okada T.; Yasuhara A.; Nakatsuka A.; Shikata K.; Hourai S.; Futami J.; Watanabe E.; Matsuki Y.; Hiramatsu R.; Akagi S.; Makino H.; Kanwar Y.S.; Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005,102(30),10610-10615","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s00125-011-2137-1","volume":"54","author":"Kl\u00f6ting N.","year":"2011","unstructured":"Kl\u00f6ting N.; Kovacs P.; Kern M.; Heiker J.T.; Fasshauer M.; Sch\u00f6n M.R.; Stumvoll M.; Beck-Sickinger A.G.; Bl\u00fcher M.; Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 2011,54(7),1819-1823","journal-title":"Diabetologia"},{"key":"ref=262","first-page":"23","volume":"8","author":"Furuhashi M.","year":"2015","unstructured":"Furuhashi M.; Saitoh S.; Shimamoto K.; Miura T.; Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin Med Insights Cardiol 2015,8(Suppl. 3),23-33","journal-title":"Clin Med Insights Cardiol"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature03711","volume":"436","author":"Yang Q.","year":"2005","unstructured":"Yang Q.; Graham T.E.; Mody N.; Preitner F.; Peroni O.D.; Zabolotny J.M.; Kotani K.; Quadro L.; Kahn B.B.; Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005,436(7049),356-362","journal-title":"Nature"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s40618-018-0856-6","volume":"41","author":"Majerczyk M.","year":"2018","unstructured":"Majerczyk M.; Koce\u0142ak P.; Chor\u0119za P.; Arabzada H.; Owczarek A.J.; Bo\u017centowicz-Wikarek M.; Brzozowska A.; Szybalska A.; Puzianowska-Ku\u017anicka M.; Grodzicki T.; Wi\u0119cek A.; Olszanecka-Glinianowicz M.; Chudek J.; Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65\u00a0years and older. J Endocrinol Invest 2018,41(10),1211-1219","journal-title":"J Endocrinol Invest"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2265.2007.03072.x","volume":"68","author":"Seo J.A.","year":"2008","unstructured":"Seo J.A.; Kim N.H.; Park S.Y.; Kim H.Y.; Ryu O.H.; Lee K.W.; Lee J.; Kim D.L.; Choi K.M.; Baik S.H.; Choi D.S.; Kim S.G.; Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol (Oxf) 2008,68(4),555-560","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/obr.12333","volume":"17","author":"Bekaert M.","year":"2016","unstructured":"Bekaert M.; Verhelst X.; Geerts A.; Lapauw B.; Calders P.; Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: A systematic review. Obes Rev 2016,17(1),68-80","journal-title":"Obes Rev"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/MCG.0b013e3181a0998d","volume":"43","author":"Alkhouri N.","year":"2009","unstructured":"Alkhouri N.; Lopez R.; Berk M.; Feldstein A.E.; Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease. J Clin Gastroenterol 2009,43(10),985-989","journal-title":"J Clin Gastroenterol"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/cphy.c160004","volume":"6","author":"Kaji H.","year":"2016","unstructured":"Kaji H.; Adipose tissue-derived plasminogen activator inhibitor-1 function and regulation. Compr Physiol 2016,6(4),1873-1896","journal-title":"Compr Physiol"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/jcp.44.2.139","volume":"44","author":"Simpson A.J.","year":"1991","unstructured":"Simpson A.J.; Booth N.A.; Moore N.R.; Bennett B.; Distribution of plasminogen activator inhibitor (PAI-1) in tissues. J Clin Pathol 1991,44(2),139-143","journal-title":"J Clin Pathol"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"e0137612","DOI":"10.1371\/journal.pone.0137612","volume":"10","author":"Aubin K.","year":"2015","unstructured":"Aubin K.; Safoine M.; Proulx M.; Audet-Casgrain M.A.; C\u00f4t\u00e9 J.F.T.; T\u00eatu F.A.; Roy A.; Fradette J.; Characterization of in vitro engineered human adipose tissues: Relevant adipokine secretion and impact of TNF-\u03b1. PLoS One 2015,10(9),e0137612","journal-title":"PLoS One"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/sj.ijo.0802778","volume":"28","author":"Skurk T.","year":"2004","unstructured":"Skurk T.; Hauner H.; Obesity and impaired fibrinolysis: Role of adipose production of plasminogen activator inhibitor-1. Int J Obes Relat Metab Disord 2004,28(11),1357-1364","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.1152\/ajpendo.00605.2004","volume":"290","author":"Liang X.","year":"2006","unstructured":"Liang X.; Kanjanabuch T.; Mao S.L.; Hao C.M.; Tang Y.W.; Declerck P.J.; Hasty A.H.; Wasserman D.H.; Fogo A.B.; Ma L.J.; Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab 2006,290(1),E103-E113","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1160\/TH08-06-0401","volume":"101","author":"Scroyen I.","year":"2009","unstructured":"Scroyen I.; Jacobs F.; Cosemans L.; De Geest B.; Lijnen H.R.; Effect of plasminogen activator inhibitor-1 on adipogenesis in vivo. Thromb Haemost 2009,101(2),388-393","journal-title":"Thromb Haemost"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2337\/diabetes.53.2.336","volume":"53","author":"Ma L.J.","year":"2004","unstructured":"Ma L.J.; Mao S.L.; Taylor K.L.; Kanjanabuch T.; Guan Y.; Zhang Y.; Brown N.J.; Swift L.L.; McGuinness O.P.; Wasserman D.H.; Vaughan D.E.; Fogo A.B.; Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 2004,53(2),336-346","journal-title":"Diabetes"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1038\/nutd.2014.43","volume":"5","author":"Wolfs M.G.","year":"2015","unstructured":"Wolfs M.G.; Gruben N.; Rensen S.S.; Verdam F.J.; Greve J.W.; Driessen A.; Wijmenga C.; Buurman W.A.; Franke L.; Scheja L.; Koonen D.P.; Shiri-Sverdlov R.; van Haeften T.W.; Hofker M.H.; Fu J.; Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity. Nutr Diabetes 2015,5,e146","journal-title":"Nutr Diabetes"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1210\/en.2011-0068","volume":"152","author":"de Castro J.","year":"2011","unstructured":"de Castro J.; Sevillano J.; Marciniak J.; Rodriguez R.; Gonz\u00e1lez-Mart\u00edn C.; Viana M.; Eun-suk O.H.; de Mouzon S.H.; Herrera E.; Ramos M.P.; Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy. Endocrinology 2011,152(11),4094-4105","journal-title":"Endocrinology"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/181684","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/181684\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/181684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T18:43:23Z","timestamp":1626979403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181684\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":276,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866527666200505214555","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}